Skip to content
Industry
This is research, not advice. We’re not SEBI-registered.

FDC share price today

FDC Ltd · NSE: FDC · Pharma - Formulators · price as of the 4 November 2026 close, updated every trading day · results updated weekly · research updated 16 November 2023

FDC share price today: ₹390.95 at the NSE close on 4 November 2026, down 8.2% in a year. FDC (NSE: FDC) is worth ₹6,365 crore, trades at a P/E of 19.4 and has closed between ₹321.10 and ₹433.80 over the past 52 weeks. Latest change: profit up, share price behind the market.

Turning aroundBusiness trend from the last 12 quarters
₹390.95Price −8.2% in a year
19.4×P/E lower than 67% of the last 11 years
₹572 CrRevenue (Sep 2026) +20.9% on a year ago
₹49.0 CrProfit (Sep 2026) +75.0% on a year ago
11.0%Operating margin +4.0 points on a year ago
15%ROCE FY26
11.9%ROIC against a 12.0% cost of capital: −0.1 points

FDC Ltd's earnings have grown faster than its share price. Earnings per share grew +5.5% in a year while the price moved −8.2%.

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business.

The price has been falling for 10 weeks, and the P/E is lower than 67% of its own last 11 years. Over the last four quarters, results have been improving, with profit +75.0% on a year earlier, and 87% of the last 3 years' profit came in as cash. What will decide it: the next one or two quarters of results.

What is the FDC share price today?

FDC Ltd's share price was ₹390.95 at the close on 4 November 2026. It has been falling for 10 weeks. That is 3.6% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹321 and ₹434, and at that close it sat 62% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today FDC Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 1 week in a row.

1Y

Nov 2026: ₹391, 3.6% above its 200-day average. The price has been falling for 10 weeks.

  • Price ₹391
  • 50-day avg ₹354
  • 200-day avg ₹378
Nov 2026: ₹391, 3.6% above its 200-day average. The price has been falling for 10 weeks.
WeekPrice50-day avg200-day avg
31 Oct 2025₹461₹455₹462
7 Nov 2025₹426₹453₹461
14 Nov 2025₹409₹445₹458
21 Nov 2025₹411₹439₹456
28 Nov 2025₹414₹435₹454
5 Dec 2025₹414₹431₹452
12 Dec 2025₹419₹429₹450
19 Dec 2025₹411₹426₹449
26 Dec 2025₹407₹424₹447
2 Jan 2026₹420₹423₹446
9 Jan 2026₹400₹420₹444
16 Jan 2026₹385₹416₹442
23 Jan 2026₹370₹409₹439
1 Feb 2026₹378₹402₹436
6 Feb 2026₹368₹398₹433
13 Feb 2026₹376₹396₹431
20 Feb 2026₹369₹392₹428
27 Feb 2026₹357₹387₹425
6 Mar 2026₹362₹385₹423
13 Mar 2026₹353₹381₹420
20 Mar 2026₹333₹374₹416
27 Mar 2026₹321₹367₹412
17 Apr 2026₹358₹358₹405
24 Apr 2026₹366₹360₹403
30 Apr 2026₹364₹360₹401
8 May 2026₹380₹363₹400
15 May 2026₹366₹364₹399
22 May 2026₹373₹365₹397
29 May 2026₹405₹370₹397
4 Jun 2026₹401₹374₹397
5 Jun 2026₹381₹374₹397
10 Jun 2026₹381₹376₹397
12 Jun 2026₹388₹376₹396
17 Jun 2026₹381₹377₹396
19 Jun 2026₹389₹378₹396
24 Jun 2026₹411₹381₹396
25 Jun 2026₹408₹382₹396
1 Jul 2026₹431₹387₹397
3 Jul 2026₹434₹391₹398
10 Jul 2026₹432₹398₹399
17 Jul 2026₹420₹402₹401
24 Jul 2026₹413₹404₹401
31 Jul 2026₹410₹405₹402
7 Aug 2026₹370₹402₹401
14 Aug 2026₹354₹394₹399
21 Aug 2026₹349₹386₹396
28 Aug 2026₹343₹378₹394
4 Sep 2026₹343₹371₹391
11 Sep 2026₹341₹367₹389
18 Sep 2026₹353₹364₹387
25 Sep 2026₹341₹362₹386
1 Oct 2026₹336₹359₹384
9 Oct 2026₹330₹354₹381
16 Oct 2026₹356₹352₹380
23 Oct 2026₹339₹351₹378
30 Oct 2026₹377₹354₹378
4 Nov 2026₹391₹354₹378
Weekly closing price (₹) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 1-year window.

3Y

Nov 2026: ₹391, 3.6% above its 200-day average. The price has been falling for 10 weeks.

  • Price ₹391
  • 50-day avg ₹354
  • 200-day avg ₹378
Nov 2026: ₹391, 3.6% above its 200-day average. The price has been falling for 10 weeks.
WeekPrice50-day avg200-day avg
3 Nov 2023₹362₹370₹333
12 Nov 2023₹387₹371₹335
17 Nov 2023₹387₹373₹337
24 Nov 2023₹406₹378₹340
1 Dec 2023₹397₹381₹342
8 Dec 2023₹404₹385₹346
15 Dec 2023₹402₹389₹348
22 Dec 2023₹392₹389₹350
29 Dec 2023₹396₹390₹352
5 Jan 2024₹415₹393₹355
12 Jan 2024₹425₹396₹358
20 Jan 2024₹438₹403₹362
25 Jan 2024₹417₹405₹363
2 Feb 2024₹423₹407₹366
9 Feb 2024₹447₹414₹370
16 Feb 2024₹436₹419₹373
23 Feb 2024₹472₹426₹377
2 Mar 2024₹446₹431₹382
7 Mar 2024₹449₹435₹385
15 Mar 2024₹428₹434₹387
22 Mar 2024₹430₹434₹389
28 Mar 2024₹425₹432₹390
5 Apr 2024₹452₹434₹393
12 Apr 2024₹451₹437₹395
19 Apr 2024₹449₹439₹397
26 Apr 2024₹457₹441₹400
3 May 2024₹449₹443₹402
10 May 2024₹440₹444₹404
18 May 2024₹484₹448₹408
24 May 2024₹470₹452₹410
31 May 2024₹433₹453₹413
7 Jun 2024₹443₹450₹414
14 Jun 2024₹461₹451₹416
21 Jun 2024₹461₹452₹417
28 Jun 2024₹462₹454₹420
5 Jul 2024₹515₹461₹423
12 Jul 2024₹491₹468₹427
19 Jul 2024₹486₹471₹429
26 Jul 2024₹502₹477₹433
2 Aug 2024₹509₹483₹437
9 Aug 2024₹489₹486₹440
16 Aug 2024₹482₹485₹441
23 Aug 2024₹537₹491₹445
30 Aug 2024₹543₹499₹449
6 Sep 2024₹571₹510₹455
13 Sep 2024₹597₹524₹461
20 Sep 2024₹564₹532₹466
27 Sep 2024₹541₹536₹471
4 Oct 2024₹519₹535₹473
11 Oct 2024₹536₹534₹476
18 Oct 2024₹539₹537₹479
25 Oct 2024₹516₹534₹481
1 Nov 2024₹552₹534₹484
8 Nov 2024₹514₹533₹486
14 Nov 2024₹496₹529₹487
22 Nov 2024₹488₹522₹487
29 Nov 2024₹512₹520₹488
6 Dec 2024₹515₹519₹489
13 Dec 2024₹504₹518₹490
20 Dec 2024₹492₹515₹491
27 Dec 2024₹500₹513₹491
3 Jan 2025₹510₹511₹492
10 Jan 2025₹489₹508₹492
17 Jan 2025₹482₹503₹491
24 Jan 2025₹471₹498₹491
1 Feb 2025₹483₹493₹490
7 Feb 2025₹472₹490₹489
14 Feb 2025₹405₹480₹486
21 Feb 2025₹403₹466₹482
28 Feb 2025₹382₹456₹479
7 Mar 2025₹402₹445₹475
13 Mar 2025₹391₹437₹472
21 Mar 2025₹414₹432₹468
28 Mar 2025₹394₹426₹465
4 Apr 2025₹398₹422₹463
11 Apr 2025₹422₹421₹461
17 Apr 2025₹430₹421₹460
25 Apr 2025₹426₹423₹458
2 May 2025₹423₹423₹457
9 May 2025₹430₹424₹455
16 May 2025₹441₹427₹455
23 May 2025₹466₹433₹455
30 May 2025₹439₹436₹455
6 Jun 2025₹429₹436₹454
13 Jun 2025₹476₹440₹454
20 Jun 2025₹455₹445₹455
27 Jun 2025₹480₹450₹456
4 Jul 2025₹489₹457₹457
11 Jul 2025₹501₹466₹460
18 Jul 2025₹490₹471₹461
25 Jul 2025₹489₹475₹463
1 Aug 2025₹475₹476₹464
8 Aug 2025₹475₹476₹464
14 Aug 2025₹477₹477₹465
22 Aug 2025₹475₹477₹466
29 Aug 2025₹458₹475₹465
5 Sep 2025₹471₹473₹465
12 Sep 2025₹463₹471₹465
19 Sep 2025₹487₹471₹466
26 Sep 2025₹454₹471₹466
3 Oct 2025₹461₹469₹465
10 Oct 2025₹456₹466₹465
17 Oct 2025₹438₹461₹464
24 Oct 2025₹430₹458₹463
31 Oct 2025₹461₹455₹462
7 Nov 2025₹426₹453₹461
14 Nov 2025₹409₹445₹458
21 Nov 2025₹411₹439₹456
28 Nov 2025₹414₹435₹454
5 Dec 2025₹414₹431₹452
12 Dec 2025₹419₹429₹450
19 Dec 2025₹411₹426₹449
26 Dec 2025₹407₹424₹447
2 Jan 2026₹420₹423₹446
9 Jan 2026₹400₹420₹444
16 Jan 2026₹385₹416₹442
23 Jan 2026₹370₹409₹439
1 Feb 2026₹378₹402₹436
6 Feb 2026₹368₹398₹433
13 Feb 2026₹376₹396₹431
20 Feb 2026₹369₹392₹428
27 Feb 2026₹357₹387₹425
6 Mar 2026₹362₹385₹423
13 Mar 2026₹353₹381₹420
20 Mar 2026₹333₹374₹416
27 Mar 2026₹321₹367₹412
17 Apr 2026₹358₹358₹405
24 Apr 2026₹366₹360₹403
30 Apr 2026₹364₹360₹401
8 May 2026₹380₹363₹400
15 May 2026₹366₹364₹399
22 May 2026₹373₹365₹397
29 May 2026₹405₹370₹397
4 Jun 2026₹401₹374₹397
5 Jun 2026₹381₹374₹397
10 Jun 2026₹381₹376₹397
12 Jun 2026₹388₹376₹396
17 Jun 2026₹381₹377₹396
19 Jun 2026₹389₹378₹396
24 Jun 2026₹411₹381₹396
25 Jun 2026₹408₹382₹396
1 Jul 2026₹431₹387₹397
3 Jul 2026₹434₹391₹398
10 Jul 2026₹432₹398₹399
17 Jul 2026₹420₹402₹401
24 Jul 2026₹413₹404₹401
31 Jul 2026₹410₹405₹402
7 Aug 2026₹370₹402₹401
14 Aug 2026₹354₹394₹399
21 Aug 2026₹349₹386₹396
28 Aug 2026₹343₹378₹394
4 Sep 2026₹343₹371₹391
11 Sep 2026₹341₹367₹389
18 Sep 2026₹353₹364₹387
25 Sep 2026₹341₹362₹386
1 Oct 2026₹336₹359₹384
9 Oct 2026₹330₹354₹381
16 Oct 2026₹356₹352₹380
23 Oct 2026₹339₹351₹378
30 Oct 2026₹377₹354₹378
4 Nov 2026₹391₹354₹378
Weekly closing price (₹) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 3-year window.

5Y

Nov 2026: ₹391, 3.6% above its 200-day average. The price has been falling for 10 weeks.

  • Price ₹391
  • 50-day avg ₹354
  • 200-day avg ₹378
Nov 2026: ₹391, 3.6% above its 200-day average. The price has been falling for 10 weeks.
WeekPrice50-day avg200-day avg
29 Oct 2021₹319₹345₹335
12 Nov 2021₹306₹338₹334
26 Nov 2021₹290₹323₹330
10 Dec 2021₹295₹311₹326
24 Dec 2021₹290₹303₹322
7 Jan 2022₹305₹302₹320
21 Jan 2022₹285₹301₹318
4 Feb 2022₹294₹297₹316
18 Feb 2022₹296₹300₹315
4 Mar 2022₹270₹292₹311
17 Mar 2022₹262₹283₹307
1 Apr 2022₹269₹276₹303
13 Apr 2022₹281₹277₹301
29 Apr 2022₹269₹277₹299
13 May 2022₹245₹271₹295
27 May 2022₹246₹263₹290
10 Jun 2022₹240₹257₹286
24 Jun 2022₹232₹249₹281
8 Jul 2022₹249₹248₹278
22 Jul 2022₹254₹250₹276
5 Aug 2022₹273₹253₹274
19 Aug 2022₹261₹256₹273
2 Sep 2022₹274₹259₹272
16 Sep 2022₹277₹265₹273
30 Sep 2022₹264₹267₹273
14 Oct 2022₹285₹271₹273
28 Oct 2022₹308₹279₹275
11 Nov 2022₹314₹287₹278
25 Nov 2022₹293₹287₹279
9 Dec 2022₹284₹286₹280
23 Dec 2022₹267₹284₹280
6 Jan 2023₹273₹280₹279
20 Jan 2023₹260₹276₹278
3 Feb 2023₹256₹270₹276
17 Feb 2023₹267₹269₹275
3 Mar 2023₹260₹268₹274
17 Mar 2023₹250₹264₹273
31 Mar 2023₹256₹261₹271
13 Apr 2023₹267₹262₹271
28 Apr 2023₹295₹269₹272
12 May 2023₹299₹278₹274
26 May 2023₹290₹282₹276
9 Jun 2023₹298₹287₹278
23 Jun 2023₹315₹295₹281
7 Jul 2023₹339₹304₹285
21 Jul 2023₹335₹312₹289
4 Aug 2023₹377₹325₹295
18 Aug 2023₹390₹346₹303
1 Sep 2023₹380₹358₹311
15 Sep 2023₹373₹366₹318
29 Sep 2023₹384₹369₹323
13 Oct 2023₹385₹372₹328
27 Oct 2023₹364₹371₹331
12 Nov 2023₹387₹371₹335
24 Nov 2023₹406₹378₹340
8 Dec 2023₹404₹385₹346
22 Dec 2023₹392₹389₹350
5 Jan 2024₹415₹393₹355
20 Jan 2024₹438₹403₹362
2 Feb 2024₹423₹407₹366
16 Feb 2024₹436₹419₹373
2 Mar 2024₹446₹431₹382
15 Mar 2024₹428₹434₹387
28 Mar 2024₹425₹432₹390
12 Apr 2024₹451₹437₹395
26 Apr 2024₹457₹441₹400
10 May 2024₹440₹444₹404
24 May 2024₹470₹452₹410
7 Jun 2024₹443₹450₹414
21 Jun 2024₹461₹452₹417
5 Jul 2024₹515₹461₹423
19 Jul 2024₹486₹471₹429
2 Aug 2024₹509₹483₹437
16 Aug 2024₹482₹485₹441
30 Aug 2024₹543₹499₹449
13 Sep 2024₹597₹524₹461
27 Sep 2024₹541₹536₹471
11 Oct 2024₹536₹534₹476
25 Oct 2024₹516₹534₹481
8 Nov 2024₹514₹533₹486
22 Nov 2024₹488₹522₹487
6 Dec 2024₹515₹519₹489
20 Dec 2024₹492₹515₹491
3 Jan 2025₹510₹511₹492
17 Jan 2025₹482₹503₹491
1 Feb 2025₹483₹493₹490
14 Feb 2025₹405₹480₹486
28 Feb 2025₹382₹456₹479
13 Mar 2025₹391₹437₹472
28 Mar 2025₹394₹426₹465
11 Apr 2025₹422₹421₹461
25 Apr 2025₹426₹423₹458
9 May 2025₹430₹424₹455
23 May 2025₹466₹433₹455
6 Jun 2025₹429₹436₹454
20 Jun 2025₹455₹445₹455
4 Jul 2025₹489₹457₹457
18 Jul 2025₹490₹471₹461
1 Aug 2025₹475₹476₹464
14 Aug 2025₹477₹477₹465
29 Aug 2025₹458₹475₹465
12 Sep 2025₹463₹471₹465
26 Sep 2025₹454₹471₹466
10 Oct 2025₹456₹466₹465
24 Oct 2025₹430₹458₹463
7 Nov 2025₹426₹453₹461
21 Nov 2025₹411₹439₹456
5 Dec 2025₹414₹431₹452
19 Dec 2025₹411₹426₹449
2 Jan 2026₹420₹423₹446
16 Jan 2026₹385₹416₹442
1 Feb 2026₹378₹402₹436
13 Feb 2026₹376₹396₹431
27 Feb 2026₹357₹387₹425
13 Mar 2026₹353₹381₹420
27 Mar 2026₹321₹367₹412
24 Apr 2026₹366₹360₹403
8 May 2026₹380₹363₹400
22 May 2026₹373₹365₹397
4 Jun 2026₹401₹374₹397
10 Jun 2026₹381₹376₹397
17 Jun 2026₹381₹377₹396
24 Jun 2026₹411₹381₹396
1 Jul 2026₹431₹387₹397
10 Jul 2026₹432₹398₹399
24 Jul 2026₹413₹404₹401
7 Aug 2026₹370₹402₹401
21 Aug 2026₹349₹386₹396
4 Sep 2026₹343₹371₹391
18 Sep 2026₹353₹364₹387
1 Oct 2026₹336₹359₹384
16 Oct 2026₹356₹352₹380
30 Oct 2026₹377₹354₹378
4 Nov 2026₹391₹354₹378
Weekly closing price (₹) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 5-year window.

10Y

Nov 2026: ₹391, 3.6% above its 200-day average. The price has been falling for 10 weeks.

  • Price ₹391
  • 50-day avg ₹354
  • 200-day avg ₹378
Nov 2026: ₹391, 3.6% above its 200-day average. The price has been falling for 10 weeks.
WeekPrice50-day avg200-day avg
30 Oct 2016₹228₹214₹199
18 Nov 2016₹218₹216₹201
9 Dec 2016₹223₹216₹203
30 Dec 2016₹221₹217₹205
20 Jan 2017₹215₹218₹207
10 Feb 2017₹210₹216₹208
3 Mar 2017₹211₹214₹209
24 Mar 2017₹204₹211₹209
13 Apr 2017₹202₹208₹208
5 May 2017₹190₹204₹207
26 May 2017₹177₹194₹203
16 Jun 2017₹182₹190₹201
7 Jul 2017₹187₹187₹199
28 Jul 2017₹183₹186₹197
18 Aug 2017₹173₹181₹194
8 Sep 2017₹172₹176₹191
29 Sep 2017₹187₹178₹189
19 Oct 2017₹185₹181₹189
10 Nov 2017₹200₹187₹189
1 Dec 2017₹211₹196₹192
22 Dec 2017₹234₹205₹195
12 Jan 2018₹243₹222₹202
2 Feb 2018₹228₹228₹206
23 Feb 2018₹289₹250₹216
16 Mar 2018₹281₹265₹225
6 Apr 2018₹256₹261₹229
27 Apr 2018₹244₹259₹232
18 May 2018₹243₹253₹234
8 Jun 2018₹235₹245₹234
29 Jun 2018₹226₹240₹234
20 Jul 2018₹227₹237₹234
10 Aug 2018₹245₹240₹236
31 Aug 2018₹246₹243₹237
21 Sep 2018₹238₹244₹238
12 Oct 2018₹208₹228₹234
2 Nov 2018₹202₹217₹230
22 Nov 2018₹186₹208₹226
14 Dec 2018₹180₹197₹220
4 Jan 2019₹174₹188₹214
25 Jan 2019₹160₹180₹208
15 Feb 2019₹152₹172₹202
8 Mar 2019₹174₹168₹197
29 Mar 2019₹166₹171₹194
18 Apr 2019₹164₹169₹190
10 May 2019₹165₹168₹188
31 May 2019₹196₹175₹187
21 Jun 2019₹176₹177₹186
12 Jul 2019₹168₹177₹185
2 Aug 2019₹156₹169₹181
23 Aug 2019₹159₹166₹179
13 Sep 2019₹172₹165₹177
4 Oct 2019₹169₹168₹176
27 Oct 2019₹171₹166₹175
15 Nov 2019₹184₹171₹175
6 Dec 2019₹206₹182₹178
27 Dec 2019₹209₹192₹181
17 Jan 2020₹231₹204₹187
7 Feb 2020₹240₹216₹193
28 Feb 2020₹235₹230₹200
20 Mar 2020₹202₹224₹203
9 Apr 2020₹239₹215₹202
30 Apr 2020₹245₹227₹207
22 May 2020₹240₹234₹212
12 Jun 2020₹243₹241₹217
3 Jul 2020₹266₹253₹224
24 Jul 2020₹272₹257₹229
14 Aug 2020₹324₹284₹241
4 Sep 2020₹319₹302₹253
25 Sep 2020₹335₹318₹264
16 Oct 2020₹348₹333₹276
6 Nov 2020₹332₹336₹285
27 Nov 2020₹343₹333₹291
18 Dec 2020₹345₹340₹299
8 Jan 2021₹329₹336₹303
29 Jan 2021₹291₹326₹304
19 Feb 2021₹295₹310₹302
12 Mar 2021₹294₹300₹300
1 Apr 2021₹288₹291₹298
23 Apr 2021₹306₹297₹298
14 May 2021₹335₹308₹301
4 Jun 2021₹337₹323₹307
25 Jun 2021₹352₹336₹313
16 Jul 2021₹379₹350₹321
6 Aug 2021₹360₹359₹327
27 Aug 2021₹339₹352₹329
17 Sep 2021₹362₹353₹332
8 Oct 2021₹354₹353₹335
29 Oct 2021₹319₹345₹335
18 Nov 2021₹282₹331₹333
10 Dec 2021₹295₹311₹326
31 Dec 2021₹304₹302₹321
21 Jan 2022₹285₹301₹318
11 Feb 2022₹305₹299₹315
4 Mar 2022₹270₹292₹311
25 Mar 2022₹257₹279₹305
13 Apr 2022₹281₹277₹301
6 May 2022₹267₹276₹297
27 May 2022₹246₹263₹290
17 Jun 2022₹240₹253₹284
8 Jul 2022₹249₹248₹278
29 Jul 2022₹254₹251₹274
19 Aug 2022₹261₹256₹273
9 Sep 2022₹276₹262₹273
30 Sep 2022₹264₹267₹273
21 Oct 2022₹292₹275₹274
11 Nov 2022₹314₹287₹278
2 Dec 2022₹284₹287₹279
23 Dec 2022₹267₹284₹280
13 Jan 2023₹270₹279₹279
3 Feb 2023₹256₹270₹276
24 Feb 2023₹269₹269₹275
17 Mar 2023₹250₹264₹273
6 Apr 2023₹265₹261₹271
28 Apr 2023₹295₹269₹272
19 May 2023₹287₹281₹275
9 Jun 2023₹298₹287₹278
30 Jun 2023₹310₹298₹282
21 Jul 2023₹335₹312₹289
11 Aug 2023₹407₹338₹299
1 Sep 2023₹380₹358₹311
22 Sep 2023₹368₹367₹320
13 Oct 2023₹385₹372₹328
3 Nov 2023₹362₹370₹333
24 Nov 2023₹406₹378₹340
15 Dec 2023₹402₹389₹348
5 Jan 2024₹415₹393₹355
25 Jan 2024₹417₹405₹363
16 Feb 2024₹436₹419₹373
7 Mar 2024₹449₹435₹385
28 Mar 2024₹425₹432₹390
19 Apr 2024₹449₹439₹397
10 May 2024₹440₹444₹404
31 May 2024₹433₹453₹413
21 Jun 2024₹461₹452₹417
12 Jul 2024₹491₹468₹427
2 Aug 2024₹509₹483₹437
23 Aug 2024₹537₹491₹445
13 Sep 2024₹597₹524₹461
4 Oct 2024₹519₹535₹473
25 Oct 2024₹516₹534₹481
14 Nov 2024₹496₹529₹487
6 Dec 2024₹515₹519₹489
27 Dec 2024₹500₹513₹491
17 Jan 2025₹482₹503₹491
7 Feb 2025₹472₹490₹489
28 Feb 2025₹382₹456₹479
21 Mar 2025₹414₹432₹468
11 Apr 2025₹422₹421₹461
2 May 2025₹423₹423₹457
23 May 2025₹466₹433₹455
13 Jun 2025₹476₹440₹454
4 Jul 2025₹489₹457₹457
25 Jul 2025₹489₹475₹463
14 Aug 2025₹477₹477₹465
5 Sep 2025₹471₹473₹465
26 Sep 2025₹454₹471₹466
17 Oct 2025₹438₹461₹464
7 Nov 2025₹426₹453₹461
28 Nov 2025₹414₹435₹454
19 Dec 2025₹411₹426₹449
9 Jan 2026₹400₹420₹444
1 Feb 2026₹378₹402₹436
20 Feb 2026₹369₹392₹428
13 Mar 2026₹353₹381₹420
17 Apr 2026₹358₹358₹405
8 May 2026₹380₹363₹400
29 May 2026₹405₹370₹397
10 Jun 2026₹381₹376₹397
19 Jun 2026₹389₹378₹396
1 Jul 2026₹431₹387₹397
17 Jul 2026₹420₹402₹401
7 Aug 2026₹370₹402₹401
28 Aug 2026₹343₹378₹394
18 Sep 2026₹353₹364₹387
9 Oct 2026₹330₹354₹381
30 Oct 2026₹377₹354₹378
4 Nov 2026₹391₹354₹378
Weekly closing price (₹) with its 50-day and 200-day averages. The strip under the chart shows the phase: tan sideways, green rising, yellow stalling near a high, orange falling. 10-year window.

Price stage: Falling from Oct 2025 to Oct 2026.

Price stage: Rising from Nov 2023 to Feb 2025; Falling from Feb 2025 to Jul 2025; Rising from Jul 2025 to Oct 2025; Falling from Oct 2025 to Oct 2026.

Price stage: Falling from Oct 2021 to Oct 2022; Rising from Nov 2022 to Jan 2023; Falling from Feb 2023 to May 2023; Rising from Jun 2023 to Feb 2025; Falling from Feb 2025 to Jul 2025; Rising from Aug 2025 to Oct 2025; Falling from Oct 2025 to Oct 2026.

Price stage: Rising from Oct 2016 to Apr 2017; Falling from May 2017 to Dec 2017; Rising from Dec 2017 to Oct 2018; Falling from Nov 2018 to Dec 2019; Rising from Dec 2019 to Mar 2021; Falling from Apr 2021 to May 2021; Rising from Jun 2021 to Nov 2021; Falling from Dec 2021 to Oct 2022; Rising from Nov 2022 to Jan 2023; Falling from Feb 2023 to May 2023; Rising from Jun 2023 to Feb 2025; Falling from Feb 2025 to Jul 2025; Rising from Jul 2025 to Oct 2025; Falling from Nov 2025 to Oct 2026.

Week by week since 2016: did it beat the NIFTY 500 over the past 13 weeks?

Ahead in 244 of 547 weeks

Week by week since 2016: did it beat the NIFTY 500 over the past 13 weeks?
Week13-week return vs NIFTY 500
11 Mar 2016no NIFTY 500 reading
18 Mar 2016no NIFTY 500 reading
23 Mar 2016no NIFTY 500 reading
1 Apr 2016no NIFTY 500 reading
8 Apr 2016no NIFTY 500 reading
13 Apr 2016no NIFTY 500 reading
22 Apr 2016no NIFTY 500 reading
29 Apr 2016no NIFTY 500 reading
6 May 2016no NIFTY 500 reading
13 May 2016no NIFTY 500 reading
20 May 2016no NIFTY 500 reading
27 May 2016no NIFTY 500 reading
3 Jun 2016no NIFTY 500 reading
10 Jun 2016−12.2%
17 Jun 2016−7.9%
24 Jun 2016−5.4%
1 Jul 2016−9.2%
8 Jul 2016−3.9%
15 Jul 2016−5.6%
22 Jul 2016−9.0%
29 Jul 2016−5.8%
5 Aug 2016−6.5%
12 Aug 2016−9.2%
19 Aug 2016−8.2%
26 Aug 2016−8.0%
2 Sep 2016−3.0%
9 Sep 2016+14.9%
16 Sep 2016+16.6%
23 Sep 2016+13.1%
30 Sep 2016+9.2%
7 Oct 2016+9.6%
14 Oct 2016+8.8%
21 Oct 2016+15.0%
30 Oct 2016+19.1%
4 Nov 2016+16.2%
11 Nov 2016+28.2%
18 Nov 2016+22.2%
25 Nov 2016+17.2%
2 Dec 2016+20.0%
9 Dec 2016+5.5%
16 Dec 2016+7.5%
23 Dec 2016+1.7%
30 Dec 2016+10.1%
6 Jan 2017+2.8%
13 Jan 2017+3.5%
20 Jan 2017+0.2%
27 Jan 2017−7.0%
3 Feb 2017+1.1%
10 Feb 2017−14.8%
17 Feb 2017−15.2%
23 Feb 2017−10.5%
3 Mar 2017−14.2%
10 Mar 2017−18.2%
17 Mar 2017−21.8%
24 Mar 2017−17.3%
31 Mar 2017−22.9%
7 Apr 2017−17.4%
13 Apr 2017−17.9%
21 Apr 2017−15.8%
28 Apr 2017−18.8%
5 May 2017−25.9%
12 May 2017−24.0%
19 May 2017−19.7%
26 May 2017−24.1%
2 Jun 2017−19.6%
9 Jun 2017−17.7%
16 Jun 2017−19.4%
23 Jun 2017−14.2%
30 Jun 2017−15.0%
7 Jul 2017−15.3%
14 Jul 2017−16.3%
21 Jul 2017−17.0%
28 Jul 2017−15.3%
4 Aug 2017−11.3%
11 Aug 2017−9.8%
18 Aug 2017−9.7%
24 Aug 2017−7.8%
1 Sep 2017−14.0%
8 Sep 2017−13.8%
15 Sep 2017−11.5%
22 Sep 2017−1.8%
29 Sep 2017−0.7%
6 Oct 2017−0.7%
13 Oct 2017−4.8%
19 Oct 2017−2.7%
27 Oct 2017−4.9%
3 Nov 2017+8.6%
10 Nov 2017+13.0%
17 Nov 2017+11.3%
24 Nov 2017+15.5%
1 Dec 2017+21.8%
8 Dec 2017+23.0%
15 Dec 2017+17.3%
22 Dec 2017+15.3%
29 Dec 2017+26.9%
5 Jan 2018+18.4%
12 Jan 2018+25.1%
19 Jan 2018+20.5%
25 Jan 2018+26.1%
2 Feb 2018+12.4%
9 Feb 2018+39.7%
16 Feb 2018+39.5%
23 Feb 2018+38.7%
1 Mar 2018+37.1%
9 Mar 2018+30.5%
16 Mar 2018+38.4%
23 Mar 2018+10.5%
28 Mar 2018+3.5%
6 Apr 2018+9.4%
13 Apr 2018+11.2%
20 Apr 2018+13.4%
27 Apr 2018+4.3%
4 May 2018+9.6%
11 May 2018−16.6%
18 May 2018−13.8%
25 May 2018−15.5%
1 Jun 2018−20.9%
8 Jun 2018−19.3%
15 Jun 2018−14.5%
22 Jun 2018−9.7%
29 Jun 2018−11.7%
6 Jul 2018−8.8%
13 Jul 2018−7.5%
20 Jul 2018−13.1%
27 Jul 2018−4.5%
3 Aug 2018−3.9%
10 Aug 2018−1.9%
17 Aug 2018−5.2%
24 Aug 2018−7.6%
31 Aug 2018−2.1%
7 Sep 2018+2.1%
14 Sep 2018−4.4%
21 Sep 2018+2.6%
28 Sep 2018−3.7%
5 Oct 2018−12.5%
12 Oct 2018−7.7%
19 Oct 2018+2.5%
26 Oct 2018−7.9%
2 Nov 2018−12.1%
9 Nov 2018−9.5%
16 Nov 2018−15.1%
22 Nov 2018−14.1%
30 Nov 2018−15.4%
7 Dec 2018−20.5%
14 Dec 2018−24.0%
21 Dec 2018−23.1%
28 Dec 2018−19.8%
4 Jan 2019−13.8%
11 Jan 2019−21.7%
18 Jan 2019−24.8%
25 Jan 2019−20.2%
1 Feb 2019−19.8%
8 Feb 2019−16.8%
15 Feb 2019−19.1%
22 Feb 2019−15.2%
1 Mar 2019−15.3%
8 Mar 2019−8.1%
15 Mar 2019−4.2%
22 Mar 2019−5.7%
29 Mar 2019−10.0%
5 Apr 2019−8.3%
12 Apr 2019−10.2%
18 Apr 2019−11.2%
26 Apr 2019−9.6%
3 May 2019+1.8%
10 May 2019−3.9%
17 May 2019−0.2%
24 May 2019+18.0%
31 May 2019+12.0%
7 Jun 2019+4.7%
14 Jun 2019−2.7%
21 Jun 2019−1.9%
28 Jun 2019+11.7%
5 Jul 2019+8.1%
12 Jul 2019+3.0%
19 Jul 2019+2.2%
26 Jul 2019+6.6%
2 Aug 2019−5.0%
9 Aug 2019+1.5%
16 Aug 2019+4.5%
23 Aug 2019−11.8%
30 Aug 2019−7.2%
6 Sep 2019−5.8%
13 Sep 2019+6.4%
20 Sep 2019+2.1%
27 Sep 2019−1.3%
4 Oct 2019−3.1%
11 Oct 2019+0.0%
18 Oct 2019−1.9%
27 Oct 2019−0.3%
1 Nov 2019+3.5%
8 Nov 2019+0.8%
15 Nov 2019+5.5%
22 Nov 2019+12.8%
29 Nov 2019+8.2%
6 Dec 2019+19.9%
13 Dec 2019+7.0%
20 Dec 2019+11.0%
27 Dec 2019+12.3%
3 Jan 2020+20.7%
10 Jan 2020+25.3%
17 Jan 2020+38.4%
24 Jan 2020+31.1%
1 Feb 2020+26.2%
7 Feb 2020+30.5%
14 Feb 2020+31.9%
20 Feb 2020+30.1%
28 Feb 2020+27.6%
6 Mar 2020+27.8%
13 Mar 2020+37.1%
20 Mar 2020+31.8%
27 Mar 2020+23.9%
3 Apr 2020+20.1%
9 Apr 2020+36.5%
17 Apr 2020+28.0%
24 Apr 2020+36.0%
30 Apr 2020+31.9%
8 May 2020+29.0%
15 May 2020+22.9%
22 May 2020+17.1%
29 May 2020+17.2%
5 Jun 2020+11.7%
12 Jun 2020−5.4%
19 Jun 2020−2.7%
26 Jun 2020+15.2%
3 Jul 2020+10.2%
10 Jul 2020−18.2%
17 Jul 2020−7.6%
24 Jul 2020−12.1%
31 Jul 2020+2.2%
7 Aug 2020+12.0%
14 Aug 2020+7.9%
21 Aug 2020+10.5%
28 Aug 2020+16.5%
4 Sep 2020+10.0%
11 Sep 2020+16.0%
18 Sep 2020+35.4%
25 Sep 2020+13.3%
1 Oct 2020+21.2%
9 Oct 2020+34.3%
16 Oct 2020+21.4%
23 Oct 2020+21.5%
30 Oct 2020+7.9%
6 Nov 2020−12.7%
14 Nov 2020−8.9%
20 Nov 2020−11.6%
27 Nov 2020−9.7%
4 Dec 2020−12.1%
11 Dec 2020−11.5%
18 Dec 2020−25.6%
24 Dec 2020−24.3%
1 Jan 2021−26.2%
8 Jan 2021−29.6%
15 Jan 2021−30.5%
22 Jan 2021−32.9%
29 Jan 2021−40.2%
5 Feb 2021−33.6%
12 Feb 2021−32.6%
19 Feb 2021−26.6%
26 Feb 2021−36.7%
5 Mar 2021−31.4%
12 Mar 2021−24.0%
19 Mar 2021−29.8%
26 Mar 2021−23.8%
1 Apr 2021−19.8%
9 Apr 2021−6.7%
16 Apr 2021−3.5%
23 Apr 2021−7.0%
30 Apr 2021+2.4%
7 May 2021+14.1%
14 May 2021+13.8%
21 May 2021+15.4%
28 May 2021+16.9%
4 Jun 2021+13.4%
11 Jun 2021+5.2%
18 Jun 2021+16.8%
25 Jun 2021+18.3%
2 Jul 2021+15.7%
9 Jul 2021+6.0%
16 Jul 2021+9.2%
23 Jul 2021+15.5%
30 Jul 2021+9.9%
6 Aug 2021−1.8%
13 Aug 2021−2.4%
20 Aug 2021−13.3%
27 Aug 2021−8.7%
3 Sep 2021−9.5%
9 Sep 2021−8.7%
17 Sep 2021−7.0%
24 Sep 2021−11.3%
1 Oct 2021−14.7%
8 Oct 2021−18.0%
14 Oct 2021−21.9%
22 Oct 2021−26.4%
29 Oct 2021−23.7%
4 Nov 2021−21.2%
12 Nov 2021−24.6%
18 Nov 2021−23.0%
26 Nov 2021−15.9%
3 Dec 2021−18.3%
10 Dec 2021−14.2%
17 Dec 2021−19.2%
24 Dec 2021−16.4%
31 Dec 2021−13.9%
7 Jan 2022−14.2%
14 Jan 2022−12.4%
21 Jan 2022−10.1%
28 Jan 2022−10.8%
4 Feb 2022−6.6%
11 Feb 2022+3.8%
18 Feb 2022+8.4%
25 Feb 2022−2.3%
4 Mar 2022+2.3%
11 Mar 2022−4.8%
17 Mar 2022−8.0%
25 Mar 2022−11.8%
1 Apr 2022−11.2%
8 Apr 2022−4.0%
13 Apr 2022−4.7%
22 Apr 2022−0.3%
29 Apr 2022+0.3%
6 May 2022−0.9%
13 May 2022−13.6%
20 May 2022−9.3%
27 May 2022−8.8%
3 Jun 2022−9.1%
10 Jun 2022−3.9%
17 Jun 2022+2.8%
24 Jun 2022+0.2%
1 Jul 2022+2.4%
8 Jul 2022−2.5%
15 Jul 2022−1.5%
22 Jul 2022−6.6%
29 Jul 2022−9.1%
5 Aug 2022−6.8%
12 Aug 2022−2.5%
19 Aug 2022−6.6%
26 Aug 2022−1.5%
2 Sep 2022+1.9%
9 Sep 2022−2.2%
16 Sep 2022−2.4%
23 Sep 2022+9.8%
30 Sep 2022−2.3%
7 Oct 2022+6.0%
14 Oct 2022+1.6%
21 Oct 2022+8.6%
28 Oct 2022+17.5%
4 Nov 2022+8.0%
11 Nov 2022+16.9%
18 Nov 2022+6.7%
25 Nov 2022+7.0%
2 Dec 2022+0.1%
9 Dec 2022+0.9%
16 Dec 2022+0.4%
23 Dec 2022−8.8%
30 Dec 2022−0.2%
6 Jan 2023−7.0%
13 Jan 2023−8.0%
20 Jan 2023−11.1%
27 Jan 2023−13.1%
3 Feb 2023−12.6%
10 Feb 2023−11.8%
17 Feb 2023−1.2%
24 Feb 2023+0.0%
3 Mar 2023−2.3%
10 Mar 2023+0.7%
17 Mar 2023−4.3%
24 Mar 2023+2.7%
31 Mar 2023−0.9%
6 Apr 2023−0.4%
13 Apr 2023+3.1%
21 Apr 2023+12.7%
28 Apr 2023+12.8%
5 May 2023+13.7%
12 May 2023+10.3%
19 May 2023+2.1%
26 May 2023+0.0%
2 Jun 2023+6.8%
9 Jun 2023+3.8%
16 Jun 2023+11.5%
23 Jun 2023+10.0%
30 Jun 2023+8.2%
7 Jul 2023+16.4%
14 Jul 2023+9.3%
21 Jul 2023+2.4%
28 Jul 2023+6.6%
4 Aug 2023+16.6%
11 Aug 2023+27.0%
18 Aug 2023+26.3%
25 Aug 2023+24.4%
1 Sep 2023+20.1%
8 Sep 2023+24.5%
15 Sep 2023+13.2%
22 Sep 2023+10.5%
29 Sep 2023+20.5%
6 Oct 2023+7.9%
13 Oct 2023+14.5%
20 Oct 2023+12.1%
27 Oct 2023+6.3%
3 Nov 2023−5.5%
12 Nov 2023−9.5%
17 Nov 2023−4.7%
24 Nov 2023+0.6%
1 Dec 2023−3.7%
8 Dec 2023−5.5%
15 Dec 2023+0.1%
22 Dec 2023−4.8%
29 Dec 2023−9.8%
5 Jan 2024−3.3%
12 Jan 2024−2.1%
20 Jan 2024+1.7%
25 Jan 2024−3.7%
2 Feb 2024+0.3%
9 Feb 2024+2.4%
16 Feb 2024−1.5%
23 Feb 2024+4.6%
2 Mar 2024+7.2%
7 Mar 2024+6.6%
15 Mar 2024+2.1%
22 Mar 2024+5.5%
28 Mar 2024+0.8%
5 Apr 2024+1.8%
12 Apr 2024+1.3%
19 Apr 2024−4.1%
26 Apr 2024+3.4%
3 May 2024+3.1%
10 May 2024−5.7%
18 May 2024+5.5%
24 May 2024−6.7%
31 May 2024−10.2%
7 Jun 2024−13.2%
14 Jun 2024−5.5%
21 Jun 2024−4.5%
28 Jun 2024−2.2%
5 Jul 2024+4.1%
12 Jul 2024−4.6%
19 Jul 2024−2.3%
26 Jul 2024−2.1%
2 Aug 2024+3.0%
9 Aug 2024+1.9%
16 Aug 2024−10.4%
23 Aug 2024+3.1%
30 Aug 2024+12.8%
6 Sep 2024+21.8%
13 Sep 2024+22.0%
20 Sep 2024+13.8%
27 Sep 2024+10.9%
4 Oct 2024−2.0%
11 Oct 2024+7.1%
18 Oct 2024+11.4%
25 Oct 2024+6.2%
1 Nov 2024+7.6%
8 Nov 2024+8.5%
14 Nov 2024+8.8%
22 Nov 2024−5.1%
29 Nov 2024−3.1%
6 Dec 2024−9.1%
13 Dec 2024−11.7%
20 Dec 2024−4.8%
27 Dec 2024+0.1%
3 Jan 2025+4.0%
10 Jan 2025+0.1%
17 Jan 2025−4.4%
24 Jan 2025−2.2%
1 Feb 2025−7.0%
7 Feb 2025−3.6%
14 Feb 2025−12.5%
21 Feb 2025−7.4%
28 Feb 2025−13.1%
7 Mar 2025−8.7%
13 Mar 2025−13.3%
21 Mar 2025−10.7%
28 Mar 2025−16.2%
4 Apr 2025−13.4%
11 Apr 2025−13.0%
17 Apr 2025−14.6%
25 Apr 2025−13.3%
2 May 2025−13.8%
9 May 2025−16.6%
16 May 2025−0.9%
23 May 2025+4.1%
30 May 2025+2.3%
6 Jun 2025−8.4%
13 Jun 2025+11.9%
20 Jun 2025+0.4%
27 Jun 2025+11.0%
4 Jul 2025+7.2%
11 Jul 2025+9.3%
18 Jul 2025+8.4%
25 Jul 2025+10.4%
1 Aug 2025+9.7%
8 Aug 2025+9.6%
14 Aug 2025+6.3%
22 Aug 2025+1.8%
29 Aug 2025+4.0%
5 Sep 2025+10.9%
12 Sep 2025−4.9%
19 Sep 2025+7.5%
26 Sep 2025−2.7%
3 Oct 2025−3.8%
10 Oct 2025−8.6%
17 Oct 2025−12.0%
24 Oct 2025−16.0%
31 Oct 2025−7.6%
7 Nov 2025−15.3%
14 Nov 2025−17.6%
21 Nov 2025−18.6%
28 Nov 2025−13.2%
5 Dec 2025−13.5%
12 Dec 2025−9.8%
19 Dec 2025−18.5%
26 Dec 2025−14.4%
2 Jan 2026−13.0%
9 Jan 2026−12.7%
16 Jan 2026−8.1%
23 Jan 2026−10.5%
1 Feb 2026−16.9%
6 Feb 2026−13.3%
13 Feb 2026−6.9%
20 Feb 2026−7.9%
27 Feb 2026−8.4%
6 Mar 2026−8.6%
13 Mar 2026−9.0%
20 Mar 2026−9.1%
27 Mar 2026−8.9%
17 Apr 2026−10.3%
24 Apr 2026−5.9%
30 Apr 2026−6.7%
8 May 2026+5.2%
15 May 2026+0.7%
22 May 2026+6.1%
29 May 2026+11.8%
4 Jun 2026+12.6%
5 Jun 2026+6.6%
10 Jun 2026+4.6%
12 Jun 2026+6.8%
17 Jun 2026+6.6%
19 Jun 2026+10.7%
24 Jun 2026+14.0%
25 Jun 2026+10.5%
1 Jul 2026+17.4%
3 Jul 2026+10.7%
10 Jul 2026+14.4%
17 Jul 2026+9.5%
24 Jul 2026+0.8%
31 Jul 2026−2.1%
7 Aug 2026−8.5%
14 Aug 2026−11.4%
21 Aug 2026−14.2%
28 Aug 2026−11.7%
4 Sep 2026−12.4%
11 Sep 2026−15.8%
18 Sep 2026−12.5%
25 Sep 2026−17.8%
1 Oct 2026−16.4%
9 Oct 2026−17.3%
16 Oct 2026−10.6%
23 Oct 2026−11.5%
30 Oct 2026−1.3%
4 Nov 2026+13.4%
Each bar is one week, from 2016 to now (547 weeks with a reading). Green means the stock's return over the previous 13 weeks beat the NIFTY 500; red means it trailed. The colour is strongest at a gap of 25 percentage points or more. A gap means there is no reading for that week.

Over the last 11 years the share price moved +111% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

What changed at FDC this quarter?

  1. Indian funds and insurers (DIIs) raised their stake for 3 quarters in a row

    From 6.3% to 6.6% of the company by the September 2026 quarter.

  2. Started beating the market again after 13 weeks behind it

What are FDC's latest quarterly results?

For July to September 2026 (the quarter ended 30 September 2026), FDC reported revenue of ₹572 crore, up 20.9% from ₹473 crore a year earlier, and a profit of ₹49.0 crore, up 75.0% from ₹28.0 crore.

FDC results: July to September 2026 against a year earlier

FDC results: July to September 2026 against a year earlier
MeasureJuly to September 2026July to September 2025Change
Revenue₹572 crore₹473 crore+20.9%
Profit₹49.0 crore₹28.0 crore+75.0%
Earnings per share₹3.01₹1.74+73.0%
Operating margin11.0%7.0%+4.0 points

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

The newest call in our records is from 16 November 2023, about July to September 2023; a call about these results is not in our records yet.

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

What is the FDC share price history?

FDC closed at ₹390.95 on 4 November 2026, down 8.2% from ₹426.05 a year earlier (7 November 2025) and up 19.8% over five years. Its highest weekly close since March 2016 was ₹597.25 on 13 September 2024.

FDC share price: then and now

FDC share price: then and now
WhenCloseChange to 4 Nov 2026
1 week ago · 30 Oct 2026₹377.00+3.7%
1 month ago · 1 Oct 2026₹335.90+16.4%
6 months ago · 8 May 2026₹380.20+2.8%
1 year ago · 7 Nov 2025₹426.05−8.2%
3 years ago · 3 Nov 2023₹362.35+7.9%
5 years ago · 4 Nov 2021₹326.30+19.8%
10 years ago · 4 Nov 2016₹215.30+81.6%
Earliest weekly close in our records · 11 Mar 2016₹185.60+110.6%
Highest weekly close since March 2016 · 13 Sep 2024₹597.25−34.5%
Lowest weekly close since March 2016 · 15 Feb 2019₹151.85+157.5%
52-week high (weekly close) · 3 Jul 2026₹433.80−9.9%
52-week low (weekly close) · 27 Mar 2026₹321.10+21.8%

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

560 weekly closes from 11 March 2016 to 4 November 2026.

What is the latest news on FDC?

4 Nov 2026: FDC closed at ₹390.95, up 3.7% on the week and up 16.4% on the month. Results for July to September 2026: Revenue up 20.9% and profit up 75.0% on a year earlier.

Earlier

  • 11 Feb 2026: ex-date for an interim dividend of ₹5 a share.
  • 16 Nov 2023: FDC held its results call for July to September 2023.

What dividend does FDC pay?

FDC paid ₹5 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 1.28% at the ₹390.95 close on 4 November 2026. The last was an interim dividend of ₹5 a share, ex-date 11 February 2026.

FDC dividends since 1 April 2021

FDC dividends since 1 April 2021
Ex-dateDividend per shareType
11 Feb 2026Interim₹5Interim
22 Nov 2024Interim₹5Interim

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

2 of 5Of the last 5 financial years, years with an NSE dividend record

Yes. FDC Ltd paid out 29% of its profit as dividends in FY26, and it paid a dividend in 7 of its last 13 reported years.

From the NSE corporate-actions record, read 5 November 2026.

What did FDC management say on the latest results call?

On the call for July to September 2023, held on 16 November 2023, FDC's management spoke about the quarter; the main points are below.

Source: the call transcript.

From the call for July to September 2023, 16 November 2023. The July to September 2026 results are out since, so this part may be out of date until we update it.

Which stock lists is FDC on?

FDC is on one of our India lists: Pharma stocks.

Is FDC profitable?

FDC Ltd earned ₹49.0 Cr of net profit in the Sep 2026 quarter, +75.0% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹281 Cr. Over 10 years profit has grown 5.2% a year on average. That is 8.6% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned ₹28.0 Cr.

FY26 profit ₹281 Cr (+5.2% on the year before), 5.2% a year over 10 years

  • Net profit ₹281
FY26 profit ₹281 Cr (+5.2% on the year before), 5.2% a year over 10 years
QuarterNet profit
FY16₹169
FY17₹189
FY18₹174
FY19₹170
FY20₹240
FY21₹301
FY22₹216
FY23₹194
FY24₹305
FY25₹267
FY26₹281

Growth on a year earlier

  • Growth on a year earlier 5.2%
Growth on a year earlier
QuarterGrowth on a year earlier
FY1614.2%
FY1711.8%
FY18−7.9%
FY19−2.3%
FY2041.2%
FY2125.4%
FY22−28.2%
FY23−10.2%
FY2457.2%
FY25−12.5%
FY265.2%
Top: net profit each year, ₹ Cr. Below: growth on the year before, %. 11-year window. A grey bar is lower than the year before.

Sep 2026: ₹49.0 Cr (+75.0% on a year earlier), the 3rd quarter in a row of growth

  • Net profit (quarterly) ₹49.0
Sep 2026: ₹49.0 Cr (+75.0% on a year earlier), the 3rd quarter in a row of growth
QuarterNet profit (quarterly)
Dec 2023₹79
Mar 2024₹46
Jun 2024₹119
Sep 2024₹72
Dec 2024₹37
Mar 2025₹39
Jun 2025₹121
Sep 2025₹28
Dec 2025₹28
Mar 2026₹103
Jun 2026₹132
Sep 2026₹49

Growth on a year earlier

  • Growth on a year earlier 75%
Growth on a year earlier
QuarterGrowth on a year earlier
Dec 202392.7%
Mar 202448.4%
Jun 20248.2%
Sep 20242.9%
Dec 2024−53.2%
Mar 2025−15.2%
Jun 20251.7%
Sep 2025−61.1%
Dec 2025−24.3%
Mar 2026164.1%
Jun 20269.1%
Sep 202675%
Top: net profit each quarter, ₹ Cr. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Why profit moved: revenue changed +20.9% on a year earlier and the margin moved +4.0 percentage points. Most of the change came from keeping more of each sale.

On average over the last four quarters, profit changed +56.0% and revenue +10.8%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

How much revenue does FDC make, and is it growing?

FDC Ltd reported ₹572 Cr of revenue in the Sep 2026 quarter, +20.9% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. Over 10 years it has grown 8.1% a year on average. The last full year, FY26, came in at ₹2,171 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹2,290 Cr.

FY26 revenue was ₹2,171 Cr, +3.0% on the year before.

FY26 revenue ₹2,171 Cr (+3.0% on the year before), 8.1% a year over 10 years

  • Revenue ₹2,171
FY26 revenue ₹2,171 Cr (+3.0% on the year before), 8.1% a year over 10 years
QuarterRevenue
FY16₹994
FY17₹1,013
FY18₹1,074
FY19₹1,089
FY20₹1,341
FY21₹1,331
FY22₹1,525
FY23₹1,784
FY24₹1,943
FY25₹2,108
FY26₹2,171

Growth on a year earlier

  • Growth on a year earlier 3%
Growth on a year earlier
QuarterGrowth on a year earlier
FY1611.9%
FY171.9%
FY186%
FY191.4%
FY2023.1%
FY21−0.7%
FY2214.6%
FY2317%
FY248.9%
FY258.5%
FY263%
Top: revenue each year, ₹ Cr. Below: growth on the year before, %. 11-year window. A grey bar is lower than the year before.

Sep 2026: ₹572 Cr (+20.9% on a year earlier), the 4th quarter in a row of growth

  • Revenue (quarterly) ₹572
Sep 2026: ₹572 Cr (+20.9% on a year earlier), the 4th quarter in a row of growth
QuarterRevenue (quarterly)
Dec 2023₹458
Mar 2024₹462
Jun 2024₹638
Sep 2024₹514
Dec 2024₹464
Mar 2025₹492
Jun 2025₹648
Sep 2025₹473
Dec 2025₹465
Mar 2026₹585
Jun 2026₹668
Sep 2026₹572

Growth on a year earlier

  • Growth on a year earlier 20.9%
Growth on a year earlier
QuarterGrowth on a year earlier
Dec 202312%
Mar 20246.2%
Jun 202419%
Sep 20245.8%
Dec 20241.3%
Mar 20256.5%
Jun 20251.6%
Sep 2025−8%
Dec 20250.2%
Mar 202618.9%
Jun 20263.1%
Sep 202620.9%
Top: revenue each quarter, ₹ Cr. Below: growth on the same quarter a year earlier, %. Last 12 quarters. A grey bar is lower than the quarter before.

Recent pace: the last four quarters grew +10.8% on average, against 8.1% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +10.3%, against +5.1% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +38.7%, against −0.6% a year (accelerating).

How much of every ₹100 of sales does FDC keep?

FDC Ltd's operating margin was 11.0% in the Sep 2026 quarter, 4.0 percentage points higher than the same quarter a year ago. Across 13 years it has been between 14.0% and 25.0%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +4.1 percentage points on the year while gross margin changed −1.8 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

FY26: 16.0%, within a range of 14.0% to 25.0% over 13 years

  • Operating margin 16.0%
FY26: 16.0%, within a range of 14.0% to 25.0% over 13 years
QuarterOperating margin
FY1424%
FY1522%
FY1623%
FY1724%
FY1822%
FY1921%
FY2023%
FY2125%
FY2217%
FY2314%
FY2417%
FY2515%
FY2616%

Change on the year before (points)

  • Change on the year before (points) +1.0 pts
Change on the year before (points)
QuarterChange on the year before (points)
FY14–
FY15−2.0 pts
FY16+1.0 pts
FY17+1.0 pts
FY18−2.0 pts
FY19−1.0 pts
FY20+2.0 pts
FY21+2.0 pts
FY22−8.0 pts
FY23−3.0 pts
FY24+3.0 pts
FY25−2.0 pts
FY26+1.0 pts
Operating margin each year, % (top). Below: change on the year before, in percentage points. 13-year window.

Sep 2026: operating margin 11.0% (+4.0 points on a year earlier)

  • Operating margin 11.0%
Sep 2026: operating margin 11.0% (+4.0 points on a year earlier)
QuarterOperating margin
Dec 202318%
Mar 202412%
Jun 202423%
Sep 202414%
Dec 202410%
Mar 202511%
Jun 202522%
Sep 20257%
Dec 202511%
Mar 202618%
Jun 202621%
Sep 202611%

Change on a year earlier (points)

  • Change on a year earlier (points) +4.0 pts
Change on a year earlier (points)
QuarterChange on a year earlier (points)
Dec 2023+6.0 pts
Mar 2024+1.0 pts
Jun 20240.0 pts
Sep 2024−2.0 pts
Dec 2024−8.0 pts
Mar 2025−1.0 pts
Jun 2025−1.0 pts
Sep 2025−7.0 pts
Dec 2025+1.0 pts
Mar 2026+7.0 pts
Jun 2026−1.0 pts
Sep 2026+4.0 pts
Top: quarterly operating margin, %. Below: change on the same quarter a year earlier, in percentage points. Last 12 quarters. Operating profit as a share of revenue, each quarter.

Is FDC's profit turning into cash?

Over the last 3 years, 87% of FDC Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹200 Cr of operating cash against ₹281 Cr of profit. After ₹165 Cr of spending on assets, ₹35.0 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

FY26: operating cash ₹200 Cr against profit ₹281 Cr; 87% of 3 years' profit came in as cash

  • Operating cash ₹200
  • Net profit ₹281
  • Free cash ₹35
FY26: operating cash ₹200 Cr against profit ₹281 Cr; 87% of 3 years' profit came in as cash
QuarterOperating cashNet profitFree cash
FY16₹174₹169−₹133
FY17₹154₹189₹130
FY18₹150₹174₹112
FY19₹112₹170₹72
FY20₹250₹240₹209
FY21₹207₹301₹159
FY22₹162₹216₹23
FY23₹155₹194₹29
FY24₹221₹305₹137
FY25₹318₹267₹216
FY26₹200₹281₹35
Operating cash flow and net profit each year, ₹ Cr. The line is free cash flow: operating cash minus spending on assets. 11-year window, yearly figures.

FY26: operating cash was 71% of profit (87% over three years)

  • Operating cash as % of profit 71%
  • Break-even line 100%
FY26: operating cash was 71% of profit (87% over three years)
QuarterOperating cash as % of profitBreak-even line
FY16103%100%
FY1781%100%
FY1886%100%
FY1966%100%
FY20104%100%
FY2169%100%
FY2275%100%
FY2380%100%
FY2472%100%
FY25119%100%
FY2671%100%
Operating cash as a share of net profit, each year, % (line). The flat line marks 100%, meaning all of the profit came in as cash.

Why 87% of profit came in as cash: the cash cycle got 50 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner.

What to look at next: the bigger use of cash is spending on new assets, at 2.3× depreciation over three years. The next section checks what that spending is building.

Where does FDC's cash go?

FDC Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 102 days in FY26, down from 152 days in FY21. It spent ₹351 Cr on assets over the last 3 years. Customers take 26 days to pay, and stock sits for 182 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹2,171 Cr, each day of that cycle ties up about ₹5.9 Cr, so roughly ₹607 Cr is tied up in the business at any time.

FY26: customers took 26 days to pay and stock sat for 182 days, about 6.0 months of sales sitting as stock, for a full cycle of 102 days, shorter than FY21's 152.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 182 days. Customers pay about 26 days after that. Suppliers are paid at 106 days. Together that makes the 102-day cycle.

FY26: a 102-day cash cycle, −50 days compared with FY21

  • Cash cycle 102d
  • Inventory days 182d
  • Debtor days 26d
  • Payable days 106d
FY26: a 102-day cash cycle, −50 days compared with FY21
QuarterCash cycleInventory daysDebtor daysPayable days
FY1451d116d26d90d
FY1564d132d25d94d
FY1672d134d23d84d
FY1794d148d27d81d
FY1893d166d28d101d
FY19131d184d29d82d
FY20113d180d34d101d
FY21152d189d30d68d
FY22135d210d20d94d
FY23109d183d25d99d
FY24135d216d22d103d
FY25103d186d19d102d
FY26102d182d26d106d
Debtor days, inventory days, payable days and the full cash cycle, each year. 13-year window.

Spending on assets: ₹351 Cr over the last 3 years, against ₹153 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹96.0 Cr (FY26): assets paid for that are not earning yet.

FY26: capex ₹165 Cr, work in progress ₹96.0 Cr, a build-out

  • Capex ₹165
  • Work-in-progress ₹96.0
FY26: capex ₹165 Cr, work in progress ₹96.0 Cr, a build-out
QuarterCapexWork-in-progress
FY16₹307₹20
FY17₹24₹6
FY18₹38₹13
FY19₹40₹12
FY20₹41₹24
FY21₹48₹19
FY22₹139₹105
FY23₹126₹198
FY24₹84₹261
FY25₹102₹137
FY26₹165₹96
Capital spending each year, ₹ Cr, with work in progress, ₹ Cr, as the line. Quarterly capital-spending figures are not available for India, so this is yearly.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

What is FDC's P/E ratio, and how does it compare with its own history?

FDC Ltd's P/E is 19.4×, near the low end of its own history: it has been lower only 33% of the time. Its usual P/E (the middle reading) is 22.6×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Sep 2026 add up to ₹19.24.

P/E 19.4× against a usual 22.6×: near the low end of its own history: it has been lower only 33% of the time

  • P/E 18.7×
  • Median 22.6×
P/E 19.4× against a usual 22.6×: near the low end of its own history: it has been lower only 33% of the time
WeekP/EMedian
11 Mar 201624.1×22.6×
1 Apr 201623.6×22.6×
22 Apr 201623.9×22.6×
13 May 201623.3×22.6×
3 Jun 201623.7×22.6×
24 Jun 201623.7×22.6×
15 Jul 201625.1×22.6×
5 Aug 201624.1×22.6×
26 Aug 201621.1×22.6×
16 Sep 201624.8×22.6×
7 Oct 201624.2×22.6×
30 Oct 201625.0×22.6×
18 Nov 201623.9×22.6×
9 Dec 201624.5×22.6×
30 Dec 201624.3×22.6×
20 Jan 201723.6×22.6×
10 Feb 201723.1×22.6×
3 Mar 201723.1×22.6×
24 Mar 201722.4×22.6×
13 Apr 201722.2×22.6×
5 May 201720.9×22.6×
26 May 201719.5×22.6×
16 Jun 201720.0×22.6×
7 Jul 201720.5×22.6×
28 Jul 201717.2×22.6×
18 Aug 201716.4×22.6×
8 Sep 201716.2×22.6×
29 Sep 201717.6×22.6×
19 Oct 201717.5×22.6×
10 Nov 201718.9×22.6×
1 Dec 201720.0×22.6×
22 Dec 201722.1×22.6×
12 Jan 201823.0×22.6×
2 Feb 201821.6×22.6×
23 Feb 201827.3×22.6×
16 Mar 201826.6×22.6×
6 Apr 201823.7×22.6×
27 Apr 201822.6×22.6×
18 May 201822.5×22.6×
8 Jun 201821.8×22.6×
29 Jun 201820.9×22.6×
20 Jul 201821.1×22.6×
10 Aug 201822.7×22.6×
31 Aug 201824.1×22.6×
21 Sep 201823.4×22.6×
12 Oct 201820.5×22.6×
2 Nov 201819.9×22.6×
22 Nov 201818.2×22.6×
14 Dec 201817.6×22.6×
4 Jan 201917.1×22.6×
25 Jan 201915.7×22.6×
15 Feb 201914.9×22.6×
8 Mar 201917.1×22.6×
29 Mar 201916.3×22.6×
18 Apr 201916.1×22.6×
10 May 201916.2×22.6×
31 May 201919.3×22.6×
21 Jun 201917.2×22.6×
12 Jul 201916.5×22.6×
2 Aug 201915.0×22.6×
23 Aug 201915.3×22.6×
13 Sep 201916.5×22.6×
4 Oct 201916.2×22.6×
27 Oct 201916.4×22.6×
15 Nov 201916.4×22.6×
6 Dec 201918.4×22.6×
27 Dec 201918.6×22.6×
17 Jan 202020.6×22.6×
7 Feb 202018.6×22.6×
28 Feb 202018.2×22.6×
20 Mar 202015.7×22.6×
9 Apr 202018.6×22.6×
30 Apr 202019.0×22.6×
22 May 202018.6×22.6×
12 Jun 202018.9×22.6×
3 Jul 202019.0×22.6×
24 Jul 202019.4×22.6×
14 Aug 202020.1×22.6×
4 Sep 202019.8×22.6×
25 Sep 202020.8×22.6×
16 Oct 202021.3×22.6×
6 Nov 202020.4×22.6×
27 Nov 202018.7×22.6×
18 Dec 202018.8×22.6×
8 Jan 202117.9×22.6×
29 Jan 202115.9×22.6×
19 Feb 202116.1×22.6×
12 Mar 202116.0×22.6×
1 Apr 202115.6×22.6×
23 Apr 202116.6×22.6×
14 May 202118.2×22.6×
4 Jun 202118.7×22.6×
25 Jun 202119.5×22.6×
16 Jul 202121.1×22.6×
6 Aug 202120.0×22.6×
27 Aug 202118.4×22.6×
17 Sep 202119.7×22.6×
8 Oct 202119.3×22.6×
29 Oct 202117.4×22.6×
18 Nov 202116.2×22.6×
10 Dec 202116.9×22.6×
31 Dec 202117.5×22.6×
21 Jan 202216.4×22.6×
11 Feb 202220.2×22.6×
4 Mar 202217.9×22.6×
25 Mar 202217.0×22.6×
13 Apr 202218.6×22.6×
6 May 202217.7×22.6×
27 May 202218.8×22.6×
17 Jun 202218.4×22.6×
8 Jul 202219.1×22.6×
29 Jul 202219.4×22.6×
19 Aug 202222.9×22.6×
9 Sep 202224.1×22.6×
30 Sep 202223.1×22.6×
21 Oct 202225.6×22.6×
11 Nov 202227.6×22.6×
2 Dec 202227.9×22.6×
23 Dec 202226.2×22.6×
13 Jan 202326.5×22.6×
3 Feb 202325.2×22.6×
24 Feb 202325.7×22.6×
17 Mar 202323.8×22.6×
6 Apr 202325.3×22.6×
28 Apr 202328.2×22.6×
19 May 202327.4×22.6×
9 Jun 202325.5×22.6×
30 Jun 202326.5×22.6×
21 Jul 202328.7×22.6×
11 Aug 202328.4×22.6×
1 Sep 202326.6×22.6×
22 Sep 202325.7×22.6×
13 Oct 202326.9×22.6×
3 Nov 202325.3×22.6×
24 Nov 202326.3×22.6×
15 Dec 202326.0×22.6×
5 Jan 202426.9×22.6×
25 Jan 202427.1×22.6×
16 Feb 202424.5×22.6×
7 Mar 202425.3×22.6×
28 Mar 202423.9×22.6×
19 Apr 202425.2×22.6×
10 May 202424.7×22.6×
31 May 202423.1×22.6×
21 Jun 202424.6×22.6×
12 Jul 202426.2×22.6×
2 Aug 202427.1×22.6×
23 Aug 202427.8×22.6×
13 Sep 202429.7×22.6×
4 Oct 202426.9×22.6×
25 Oct 202426.7×22.6×
14 Nov 202425.5×22.6×
6 Dec 202426.5×22.6×
27 Dec 202425.7×22.6×
17 Jan 202524.8×22.6×
7 Feb 202524.3×22.6×
28 Feb 202522.7×22.6×
21 Mar 202524.6×22.6×
11 Apr 202525.0×22.6×
2 May 202525.1×22.6×
23 May 202527.7×22.6×
13 Jun 202529.0×22.6×
4 Jul 202529.7×22.6×
25 Jul 202529.7×22.6×
14 Aug 202528.9×22.6×
5 Sep 202528.5×22.6×
26 Sep 202527.5×22.6×
17 Oct 202526.5×22.6×
7 Nov 202529.7×22.6×
28 Nov 202529.7×22.6×
19 Dec 202529.7×22.6×
9 Jan 202628.9×22.6×
1 Feb 202627.3×22.6×
20 Feb 202625.9×22.6×
13 Mar 202624.8×22.6×
2 Apr 202623.4×22.6×
24 Apr 202625.7×22.6×
15 May 202625.7×22.6×
4 Jun 202622.0×22.6×
12 Jun 202621.3×22.6×
24 Jun 202622.5×22.6×
3 Jul 202623.8×22.6×
24 Jul 202622.6×22.6×
14 Aug 202618.7×22.6×
4 Sep 202618.1×22.6×
25 Sep 202618.0×22.6×
16 Oct 202618.8×22.6×
30 Oct 202618.7×22.6×

Earnings per share, 12 months

  • Earnings per share, 12 months ₹20
Earnings per share, 12 months
WeekEarnings per share, 12 months
11 Mar 2016–
1 Apr 2016₹8
22 Apr 2016₹8
13 May 2016₹8
3 Jun 2016₹8
24 Jun 2016₹8
15 Jul 2016₹8
5 Aug 2016₹8
26 Aug 2016₹8
16 Sep 2016₹8
7 Oct 2016₹9
30 Oct 2016₹9
18 Nov 2016₹9
9 Dec 2016₹9
30 Dec 2016₹9
20 Jan 2017₹9
10 Feb 2017₹9
3 Mar 2017₹9
24 Mar 2017₹9
13 Apr 2017₹9
5 May 2017₹9
26 May 2017₹9
16 Jun 2017₹9
7 Jul 2017₹9
28 Jul 2017₹9
18 Aug 2017₹9
8 Sep 2017₹9
29 Sep 2017₹11
19 Oct 2017₹11
10 Nov 2017₹11
1 Dec 2017₹11
22 Dec 2017₹11
12 Jan 2018₹11
2 Feb 2018₹11
23 Feb 2018₹11
16 Mar 2018₹11
6 Apr 2018₹11
27 Apr 2018₹11
18 May 2018₹11
8 Jun 2018₹11
29 Jun 2018₹11
20 Jul 2018₹11
10 Aug 2018₹11
31 Aug 2018₹11
21 Sep 2018₹10
12 Oct 2018₹10
2 Nov 2018₹10
22 Nov 2018₹10
14 Dec 2018₹10
4 Jan 2019₹10
25 Jan 2019₹10
15 Feb 2019₹10
8 Mar 2019₹10
29 Mar 2019₹10
18 Apr 2019₹10
10 May 2019₹10
31 May 2019₹10
21 Jun 2019₹10
12 Jul 2019₹10
2 Aug 2019₹10
23 Aug 2019₹10
13 Sep 2019₹10
4 Oct 2019₹10
27 Oct 2019₹10
15 Nov 2019₹10
6 Dec 2019₹10
27 Dec 2019₹11
17 Jan 2020₹11
7 Feb 2020₹11
28 Feb 2020₹11
20 Mar 2020₹13
9 Apr 2020₹13
30 Apr 2020₹13
22 May 2020₹13
12 Jun 2020₹13
3 Jul 2020₹14
24 Jul 2020₹14
14 Aug 2020₹14
4 Sep 2020₹14
25 Sep 2020₹16
16 Oct 2020₹16
6 Nov 2020₹16
27 Nov 2020₹16
18 Dec 2020₹18
8 Jan 2021₹18
29 Jan 2021₹18
19 Feb 2021₹18
12 Mar 2021₹18
1 Apr 2021₹18
23 Apr 2021₹18
14 May 2021₹18
4 Jun 2021₹18
25 Jun 2021₹18
16 Jul 2021₹18
6 Aug 2021₹18
27 Aug 2021₹18
17 Sep 2021₹18
8 Oct 2021₹18
29 Oct 2021₹18
18 Nov 2021₹18
10 Dec 2021₹18
31 Dec 2021₹17
21 Jan 2022₹17
11 Feb 2022₹17
4 Mar 2022₹17
25 Mar 2022₹15
13 Apr 2022₹15
6 May 2022₹15
27 May 2022₹15
17 Jun 2022₹13
8 Jul 2022₹13
29 Jul 2022₹13
19 Aug 2022₹13
9 Sep 2022₹13
30 Sep 2022₹11
21 Oct 2022₹11
11 Nov 2022₹11
2 Dec 2022₹11
23 Dec 2022₹10
13 Jan 2023₹10
3 Feb 2023₹10
24 Feb 2023₹10
17 Mar 2023₹10
6 Apr 2023₹11
28 Apr 2023₹11
19 May 2023₹11
9 Jun 2023₹11
30 Jun 2023₹12
21 Jul 2023₹12
11 Aug 2023₹12
1 Sep 2023₹12
22 Sep 2023₹14
13 Oct 2023₹14
3 Nov 2023₹14
24 Nov 2023₹14
15 Dec 2023₹14
5 Jan 2024₹15
25 Jan 2024₹15
16 Feb 2024₹15
7 Mar 2024₹15
28 Mar 2024₹18
19 Apr 2024₹18
10 May 2024₹18
31 May 2024₹18
21 Jun 2024₹19
12 Jul 2024₹19
2 Aug 2024₹19
23 Aug 2024₹19
13 Sep 2024₹19
4 Oct 2024₹19
25 Oct 2024₹19
14 Nov 2024₹19
6 Dec 2024₹19
27 Dec 2024₹19
17 Jan 2025₹19
7 Feb 2025₹19
28 Feb 2025₹19
21 Mar 2025₹17
11 Apr 2025₹17
2 May 2025₹17
23 May 2025₹17
13 Jun 2025₹17
4 Jul 2025₹16
25 Jul 2025₹16
14 Aug 2025₹16
5 Sep 2025₹16
26 Sep 2025₹17
17 Oct 2025₹17
7 Nov 2025₹17
28 Nov 2025₹17
19 Dec 2025₹14
9 Jan 2026₹14
1 Feb 2026₹14
20 Feb 2026₹14
13 Mar 2026₹14
2 Apr 2026₹14
24 Apr 2026₹14
15 May 2026₹14
4 Jun 2026₹14
12 Jun 2026₹14
24 Jun 2026₹18
3 Jul 2026₹18
24 Jul 2026₹18
14 Aug 2026₹18
4 Sep 2026₹18
25 Sep 2026₹19
16 Oct 2026₹19
30 Oct 2026₹20
Top: P/E each week. Below: earnings per share, trailing twelve months, leaving out one-off items, a step line that moves once a quarter; 11 years of history; short peaks above 30× are drawn at the top edge.

PEG 0.46: below 1.0, so the P/E is smaller than the earnings growth rate

  • PEG 0.46×
  • PEG = 1.0 1.00×
PEG 0.46: below 1.0, so the P/E is smaller than the earnings growth rate
QuarterPEGPEG = 1.0
Q3 FY240.32×1.00×
Q4 FY240.38×1.00×
Q1 FY250.64×1.00×
Q2 FY251.00×1.00×
Q4 FY263.44×1.00×
Q1 FY272.71×1.00×
Q2 FY270.46×1.00×
PEG each quarter: the P/E divided by the yearly growth rate of earnings. The flat line marks 1.0. Below it the P/E is smaller than the growth rate; above it the P/E is bigger. Worked out here as the quarter-end P/E divided by the growth in earnings per share over the last 12 months (only quarters with positive growth), because a reported quarterly PEG is not available for this stock. Last 7 quarters.
19.4×P/E · lower than 67% of its last 11 years
n/mPEG · cannot be worked out, because 3-year earnings growth is not available

Why the multiple is where it is: over the past year earnings per share moved +5.5% while the price moved −8.2%. Earnings did better than the price, which pulled the multiple down within its own range.

Where the price move came from: over 5 years the price moved +3.7% a year; about +1.9% a year came from earnings growth and about +1.8 percentage points from the multiple (the market paying more); over 10 years the price moved +6.1% a year; about +8.3% a year came from earnings growth and about −2.2 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple.

Is the FDC business getting better or worse?

FDC Ltd's business is turning around. Profit growth has swung from −21.2% at its low to +38.7%, improving for 3 quarters in a row, with ROCE rising at 16.0%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Growth year by year: revenue +3.0% in FY26, profit +5.2%

  • Revenue growth 3.0%
Growth year by year: revenue +3.0% in FY26, profit +5.2%
QuarterRevenue growth
FY1611.9%
FY171.9%
FY186%
FY191.4%
FY2023.1%
FY21−0.7%
FY2214.6%
FY2317%
FY248.9%
FY258.5%
FY263%

Profit growth, EPS growth

  • Profit growth 5.2%
  • EPS growth 5.5%
Profit growth, EPS growth
QuarterProfit growthEPS growth
FY1614.2%13.8%
FY1711.8%11.8%
FY18−7.9%−6.1%
FY19−2.3%−2.1%
FY2041.2%44%
FY2125.4%27.2%
FY22−28.2%−28.2%
FY23−10.2%−8.7%
FY2457.2%60.3%
FY25−12.5%−12.6%
FY265.2%5.5%
Growth on the year before, each year, %. Top: revenue. Below: net profit and earnings per share, on their own scale because profit growth swings much more. Zero line drawn.

Three growth lines over twelve quarters: revenue accelerating, profit accelerating

  • Revenue 10.3%
Three growth lines over twelve quarters: revenue accelerating, profit accelerating
QuarterRevenue
Dec 202313.3%
Mar 20248.9%
Jun 202412%
Sep 202411%
Dec 20248.5%
Mar 20258.5%
Jun 20253.6%
Sep 20250.2%
Dec 20250%
Mar 20263%
Jun 20263.4%
Sep 202610.3%

Profit, EPS

  • Profit 38.7%
  • EPS 38.9%
Profit, EPS
QuarterProfitEPS
Dec 202366.7%69.4%
Mar 202456.4%60%
Jun 202434.2%37.6%
Sep 202425.4%27.7%
Dec 2024−5.5%−4.4%
Mar 2025−12.5%−12%
Jun 2025−14.3%−14.4%
Sep 2025−28.8%−28.8%
Dec 2025−21.2%−21%
Mar 20264.9%5.4%
Jun 20268.2%8.7%
Sep 202638.7%38.9%
Growth on a year earlier, % at each quarter end. Top: revenue. Below: profit and earnings per share, on their own scale because they swing much more. Each is measured over the last 12 months. A gap means there is no reading for that quarter.

ROCE: the return line, worked out each quarter

  • ROCE 16%
ROCE: the return line, worked out each quarter
QuarterROCE
Dec 202319.3%
Mar 202419.1%
Jun 202420.2%
Sep 202419.2%
Dec 202417%
Mar 202516%
Jun 202515.9%
Sep 202512.6%
Dec 202512%
Mar 202615.4%
Jun 202616.1%
Sep 202616%
Operating profit over the last 12 months (before interest and tax) as a share of average capital employed (total assets minus current liabilities), %.
RisingRevenue growth · latest +10.3%, range +0.0% to +13.3%
RisingProfit growth · latest +38.7%, range −28.8% to +66.7%
RisingEPS growth · latest +38.9%, range −28.8% to +69.4%
RisingROCE · latest 16.0%, range 12.0% to 20.2%

Why it matters: a turn in growth is often where a bigger change starts. The lines say a turn is forming, so the question is whether the next quarters confirm it.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Compound annual growth rate (%)
Measure1yr3yr5yr10yr
Revenue+3.0%+6.8%+10.3%+8.1%
Profit+5.2%+13.1%−1.4%+5.2%
EPS+5.5%+13.9%−0.6%+6.2%
Share price−8.2%+2.6%+3.7%+6.1%
+20.9%Revenue growth (Sep 2026) · latest quarter against a year ago
+75.0%Profit growth (Sep 2026) · latest quarter against a year ago
8.1%Revenue, 10 years · yearly growth over the long run

How much does FDC earn on its capital?

FDC Ltd earned a ROCE of 15% in FY26. That is up from a low of 13% in FY23. Its return on capital used (ROIC) is 0.1 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses.

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

It comes from a 12.9% net margin and 0.74× asset turnover (sales divided by assets).

Why the return is what it is (FY26): a 12.9% net margin × 0.74× asset turnover × 1.17× leverage (assets divided by equity) ≈ 11.2% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.

The key test, return on capital used minus the cost of capital: 11.9% − 12.0% = −0.1 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

FY26: ROCE 15%, the climb back from FY23's 13%

  • ROCE 15%
  • ROIC (annual) 11.5%
  • Cost of capital 12%
FY26: ROCE 15%, the climb back from FY23's 13%
QuarterROCEROIC (annual)Cost of capital
FY1425%–12%
FY1521%–12%
FY1622%–12%
FY1721%–12%
FY1819%–12%
FY1917%–12%
FY2021%–12%
FY2122%–12%
FY2215%12.2%12%
FY2313%10.7%12%
FY2418%14.5%12%
FY2516%11.9%12%
FY2615%11.5%12%
Return on capital employed each year, % (line); ROIC each year, % (line). 13-year window, low years included. The flat line is the 12.0% cost of capital used on this page.

Q2 FY27: ROCE 11.6% (last 12 months) against a 12.0% cost of capital

  • ROCE (12 months) 11.6%
  • ROIC (12 months) 10.9%
  • Cost of capital 12.0%
Q2 FY27: ROCE 11.6% (last 12 months) against a 12.0% cost of capital
QuarterROCE (12 months)ROIC (12 months)Cost of capital
Q3 FY24–12.9%12%
Q4 FY2413.8%14.7%12%
Q1 FY25–14.6%12%
Q2 FY2513.2%14.9%12%
Q3 FY25–14.4%12%
Q4 FY2511.3%12.1%12%
Q1 FY26–11.8%12%
Q2 FY268.7%11.2%12%
Q3 FY26–9.2%12%
Q4 FY2611.2%9.2%12%
Q1 FY27–11.4%12%
Q2 FY2711.6%10.9%12%
ROCE and ROIC over the last 12 months, each quarter, %; the flat line is the cost of capital. Last 12 quarters, lined up with the yearly figure.

Does FDC have too much debt?

FDC Ltd has total debt of ₹13.0 Cr against shareholder equity of ₹2,669 Cr as of Sep 2026, so its debt is 0.00× its equity, which is very little. Year by year, that ratio went from 0.02 in FY22 to 0.01 in FY26. So the returns on this page come from the business, not from borrowed money.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

FY26: debt ₹15.0 Cr, 0.01× equity

  • Total debt ₹15.0
FY26: debt ₹15.0 Cr, 0.01× equity
QuarterTotal debt
FY22₹32
FY23₹28
FY24₹21
FY25₹21
FY26₹15

Debt-to-equity

  • Debt-to-equity 0.01×
Debt-to-equity
QuarterDebt-to-equity
FY220.02×
FY230.01×
FY240.01×
FY250.01×
FY260.01×
Top: total debt each year, ₹ Cr. Below: debt-to-equity, ×. 5-year window.

Sep 2026: debt ₹13.0 Cr, debt-to-equity 0.00

  • Total debt (quarterly) ₹13.0
Sep 2026: debt ₹13.0 Cr, debt-to-equity 0.00
QuarterTotal debt (quarterly)
Dec 2023₹25
Mar 2024₹21
Jun 2024₹21
Sep 2024₹20
Dec 2024₹20
Mar 2025₹21
Jun 2025₹21
Sep 2025₹21
Dec 2025₹21
Mar 2026₹15
Jun 2026₹15
Sep 2026₹13

Debt-to-equity

  • Debt-to-equity 0.00×
Debt-to-equity
QuarterDebt-to-equity
Dec 20230.01×
Mar 20240.01×
Jun 20240.01×
Sep 20240.01×
Dec 20240.01×
Mar 20250.01×
Jun 20250.01×
Sep 20250.01×
Dec 20250.01×
Mar 20260.01×
Jun 20260.01×
Sep 20260.00×
Top: total debt each quarter, ₹ Cr. Below: debt-to-equity, ×. Last 12 quarters. Indian companies report the full balance sheet every six months, so the quarter in between repeats the last reading.

What is the FDC shareholding pattern?

Foreign institutions cut their stake in FDC Ltd by 1.1 percentage points over 8 quarters, the biggest change among its owners. Foreign institutions now own 1.6% of the company. Domestic institutions moved +0.6 points over the same period, to 6.6%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Foreign institutions: −1.1 points over 8 quarters, to 1.6%; Domestic institutions: +0.6 points over 8 quarters, to 6.6%; Promoters: +0.0 points over 8 quarters, to 69.7%.

Why the owners changed: foreign institutions drove it (−1.1 points), with the other side taken by domestic institutions (+0.6 points). They reduced their stake.

Year ends: the public +0.9 points from Mar 2024 to Mar 2026

  • Promoters 69.65%
  • Foreign inst. 2.4%
  • Domestic inst. 6.29%
  • Public 21.65%
Year ends: the public +0.9 points from Mar 2024 to Mar 2026
QuarterPromotersForeign inst.Domestic inst.Public
Mar 202469.66%2.65%6.94%20.76%
Mar 202569.66%2.56%6.37%21.42%
Mar 202669.65%2.4%6.29%21.65%
Shareholding at each year end (March quarter), % of the company. 3 year ends on file.

Foreign institutions cut their stake by 1.1 points over 8 quarters

  • Promoters 69.65%
  • Foreign inst. 1.57%
  • Domestic inst. 6.59%
  • Public 22.17%
Foreign institutions cut their stake by 1.1 points over 8 quarters
QuarterPromotersForeign inst.Domestic inst.Public
Sep 202369.66%2.42%8.12%19.8%
Dec 202369.66%2.43%7.76%20.15%
Mar 202469.66%2.65%6.94%20.76%
Jun 202469.66%2.51%6.72%21.11%
Sep 202469.66%2.62%6.02%21.71%
Dec 202469.66%2.67%6.08%21.6%
Mar 202569.66%2.56%6.37%21.42%
Jun 202569.66%2.41%7.17%20.76%
Sep 202569.66%2.43%6.81%21.1%
Dec 202569.66%2.32%6.27%21.76%
Mar 202669.65%2.4%6.29%21.65%
Jun 202669.65%1.4%6.31%22.63%
Sep 202669.65%1.57%6.59%22.17%
Shareholding by owner group, % of the company, each quarter, last 13 quarters.

How far is FDC from balance-sheet trouble?

For FDC Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

How does FDC rank in its industry?

62.7 out of 100, rank 11 of 44 in Pharma - Formulators, with 85% of the evidence available.

FDC Ltd scores 62.7 out of 100 against the 44 companies it is compared with in Pharma - Formulators, ranking 11. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.

The four parts add up to the total exactly: 25.3 + 12.3 + 14.9 + 10.2 = 62.7. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Which companies is FDC compared with?

FDC ranks 11 of 44 Pharma - Formulators companies on the 4-Factor Sector Score, with 62.7 out of 100.

  1. 1Rubicon Research LtdRUBICON · leader · Most evidence points up · 83% evidence71.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 30.1/35 · Revenue 46.8% · Profit 91.4% · Operating margin change 2 points · 88% evidenceCapital efficiency 18.6/25 · ROCE 28.4% · Operating margin 24% · 100% evidenceValuation 6.2/20 · P/E 92.5× · PEG 2.31 · 65% evidenceRelative strength 16.5/20 · Lead over its industry 28.1% · Lead over NIFTY 500 53.6% · 1 year 160.5% · 70% evidence · 11 of 12 weeks aheadExact sum: 30.1 + 18.6 + 6.2 + 16.5 = 71.4 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  2. 2Kwality Pharmaceuticals LtdKPL · breaking out · Most evidence points up · 81% evidence71.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 29.9/35 · Revenue 37.9% · Profit 88.4% · Operating margin change 3 points · 88% evidenceCapital efficiency 18.0/25 · ROCE 24.1% · Operating margin 25% · 100% evidenceValuation 11.0/20 · P/E 44.2× · PEG 0.54 · 100% evidenceRelative strength 12.3/20 · Lead over its industry — · Lead over NIFTY 500 74.4% · 1 year 288.9% · 25% evidence · 9 of 9 weeks aheadExact sum: 29.9 + 18 + 11 + 12.3 = 71.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  3. 3Accent Microcell LtdACCENTMIC · leader · Most evidence points up · 65% evidence70.6out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 21.4/35 · Revenue — · Profit — · Operating margin change 7 points · 27% evidenceCapital efficiency 21.5/25 · ROCE 24.9% · Operating margin 24% · 100% evidenceValuation 9.1/20 · P/E 26.9× · PEG — · 50% evidenceRelative strength 18.6/20 · Lead over its industry 21.4% · Lead over NIFTY 500 47.6% · 1 year 132.1% · 100% evidence · 12 of 12 weeks aheadExact sum: 21.4 + 21.5 + 9.1 + 18.6 = 70.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  4. 4Glenmark Pharmaceuticals LtdGLENMARK · breaking out · Most evidence points up · 86% evidence69.3out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 29.1/35 · Revenue 32.9% · Profit 100% · Operating margin change 2 points · 88% evidenceCapital efficiency 20.4/25 · ROCE 39.8% · Operating margin 20% · 100% evidenceValuation 11.2/20 · P/E 20.8× · PEG — · 50% evidenceRelative strength 8.6/20 · Lead over its industry -11.4% · Lead over NIFTY 500 10.8% · 1 year 21.5% · 100% evidence · 9 of 12 weeks aheadExact sum: 29.1 + 20.4 + 11.2 + 8.6 = 69.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  5. 5Ajanta Pharma LtdAJANTPHARM · leader · Most evidence points up · 100% evidence69.0out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 30.3/35 · Revenue 25% · Profit 29.8% · Operating margin change 7 points · 100% evidenceCapital efficiency 21.1/25 · ROCE 34.5% · Operating margin 31% · 100% evidenceValuation 7.1/20 · P/E 34.7× · PEG 1.77 · 100% evidenceRelative strength 10.5/20 · Lead over its industry -3.5% · Lead over NIFTY 500 20% · 1 year 42.3% · 100% evidence · 11 of 12 weeks aheadExact sum: 30.3 + 21.1 + 7.1 + 10.5 = 69 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  6. 6Bliss GVS Pharma LtdBLISSGVS · leader · Most evidence points up · 82% evidence67.1out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 29.3/35 · Revenue 25% · Profit 43.1% · Operating margin change 8 points · 95% evidenceCapital efficiency 14.7/25 · ROCE 16.9% · Operating margin 26% · 76% evidenceValuation 6.4/20 · P/E 42.4× · PEG — · 50% evidenceRelative strength 16.7/20 · Lead over its industry 59% · Lead over NIFTY 500 86.2% · 1 year 312.8% · 100% evidence · 12 of 12 weeks aheadExact sum: 29.3 + 14.7 + 6.4 + 16.7 = 67.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  7. 7Lupin LtdLUPIN · quiet · Most evidence points up · 89% evidence66.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 27.9/35 · Revenue 28.2% · Profit 49.2% · Operating margin change 2 points · 88% evidenceCapital efficiency 20.4/25 · ROCE 29.9% · Operating margin 30% · 100% evidenceValuation 16.1/20 · P/E 15.4× · PEG 0.54 · 65% evidenceRelative strength 2.0/20 · Lead over its industry -24.5% · Lead over NIFTY 500 -4.7% · 1 year 2.4% · 100% evidence · 0 of 12 weeks aheadExact sum: 27.9 + 20.4 + 16.1 + 2 = 66.4 · What this means: Earnings are strong; relative strength in its sector is -24.5% and the one-year return is 2.4%.
  8. 8Fredun Pharmaceuticals LtdFREDUN · breaking out · Most evidence points up · 76% evidence65.8out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 31.9/43.75 · Revenue 50.3% · Profit 91.3% · Operating margin change 0 points · 88% evidenceCapital efficiency 19.0/31.25 · ROCE 21.5% · Operating margin 14% · 100% evidenceValuation 14.9/25 · P/E 52.7× · PEG 0.77 · 100% evidenceRelative strength: no reading this week · its 20 points are shared across the other threeExact sum: 31.9 + 19 + 14.9 = 65.8 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone.
  9. 9Ipca Laboratories LtdIPCALAB · turning · Most evidence points up · 78% evidence65.4out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 24.0/35 · Revenue 10.6% · Profit 68% · Operating margin change 6 points · 83% evidenceCapital efficiency 15.7/25 · ROCE 17% · Operating margin 24% · 76% evidenceValuation 11.0/20 · P/E 35.6× · PEG — · 50% evidenceRelative strength 14.7/20 · Lead over its industry -0.5% · Lead over NIFTY 500 23.6% · 1 year 51.7% · 100% evidence · 10 of 12 weeks aheadExact sum: 24 + 15.7 + 11 + 14.7 = 65.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  10. 10Marksans Pharma LtdMARKSANS · leader · Most evidence points up · 74% evidence65.2out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 28.7/35 · Revenue 19.6% · Profit 48% · Operating margin change 9 points · 88% evidenceCapital efficiency 18.3/25 · ROCE 18.8% · Operating margin 25% · 100% evidenceValuation 6.3/20 · P/E 26.8× · PEG 2.85 · 65% evidenceRelative strength 11.9/20 · Lead over its industry — · Lead over NIFTY 500 40.1% · 1 year 68.4% · 25% evidence · 12 of 12 weeks aheadExact sum: 28.7 + 18.3 + 6.3 + 11.9 = 65.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks.
  11. 11FDC Ltd this pageFDC · basing · Evidence leans up · 85% evidence62.7out of 100GrowthCapitalValuationRelative
    How the score adds upGrowth & earnings 25.3/35 · Revenue 10.3% · Profit 38.7% · Operating margin change 4 points · 100% evidenceCapital efficiency 12.3/25 · ROCE 15.4% · Operating margin 11% · 100% evidenceValuation 14.9/20 · P/E 18.7× · PEG 1.25 · 100% evidenceRelative strength 10.2/20 · Lead over its industry — · Lead over NIFTY 500 4.9% · 1 year -18.2% · 25% evidence · 0 of 12 weeks aheadExact sum: 25.3 + 12.3 + 14.9 + 10.2 = 62.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
  12. 12Corona Remedies LtdCORONA · turning · Evidence leans up · 73% evidence62.3out of 100GrowthCapitalValuationRelative
  13. 13Emcure Pharmaceuticals LtdEMCURE · losing its lead · Evidence leans up · 71% evidence61.8out of 100GrowthCapitalValuationRelative
  14. 14Mankind Pharma LtdMANKIND · turning · Evidence leans up · 100% evidence61.0out of 100GrowthCapitalValuationRelative
  15. 15Zydus Lifesciences LtdZYDUSLIFE · leader · Evidence leans up · 96% evidence59.5out of 100GrowthCapitalValuationRelative
  16. 16ERIS Lifesciences LtdERIS · basing · Evidence leans up · 67% evidence56.1out of 100GrowthCapitalValuationRelative
  17. 17Gufic BioSciences LtdGUFICBIO · leader · Evidence leans up · 71% evidence56.0out of 100GrowthCapitalValuationRelative
  18. 18Strides Pharma Science LtdSTAR · breaking out · Evidence leans up · 75% evidence55.3out of 100GrowthCapitalValuationRelative
  19. 19Caplin Point Laboratories LtdCAPLIPOINT · losing its lead · Evidence leans up · 96% evidence54.3out of 100GrowthCapitalValuationRelative
  20. 20Wockhardt LtdWOCKPHARMA · losing its lead · Evidence leans up · 71% evidence52.9out of 100GrowthCapitalValuationRelative
  21. 21Kilitch Drugs (India) LtdKILITCH · breaking out · Evidence leans up · 78% evidence51.3out of 100GrowthCapitalValuationRelative
  22. 22Akums Drugs & Pharmaceuticals LtdAKUMS · leader · Evidence leans up · 71% evidence50.9out of 100GrowthCapitalValuationRelative
  23. 23Alembic Pharmaceuticals LtdAPLLTD · turning · Evidence leans down · 81% evidence47.9out of 100GrowthCapitalValuationRelative
  24. 24Alkem Laboratories LtdALKEM · quiet · Evidence leans down · 78% evidence47.6out of 100GrowthCapitalValuationRelative
  25. 25Bajaj Healthcare LtdBAJAJHCARE · quiet · Evidence leans down · 100% evidence46.6out of 100GrowthCapitalValuationRelative
  26. 26Lincoln Pharmaceuticals LtdLINCOLN · quiet · Evidence leans down · 100% evidence45.9out of 100GrowthCapitalValuationRelative
  27. 27Bharat Parenterals LtdBPLPHARMA · breaking out · Too little evidence to rank firmly · 52% evidence45.9out of 100GrowthCapitalValuationRelative
  28. 28Aurobindo Pharma LtdAUROPHARMA · leader · Evidence leans down · 96% evidence45.6out of 100GrowthCapitalValuationRelative
  29. 29Amrutanjan Health Care LtdAMRUTANJAN · turning · Evidence leans down · 96% evidence44.9out of 100GrowthCapitalValuationRelative
  30. 30RPG Life Sciences LtdRPGLIFE · losing its lead · Evidence leans down · 100% evidence43.1out of 100GrowthCapitalValuationRelative
  31. 31J B Chemicals & Pharmaceuticals LtdJBCHEPHARM · Too little evidence to rank firmly · 59% evidence42.4out of 100GrowthCapitalValuationRelative
  32. 32Zim Laboratories LtdZIMLAB · leader · Evidence leans down · 71% evidence40.7out of 100GrowthCapitalValuationRelative
  33. 33Sun Pharmaceutical Industries LtdSUNPHARMA · quiet · Evidence leans down · 100% evidence39.3out of 100GrowthCapitalValuationRelative
  34. 34Dr Reddys Laboratories LtdDRREDDY · turning · Evidence leans down · 100% evidence39.3out of 100GrowthCapitalValuationRelative
  35. 35Natco Pharma LtdNATCOPHARM · quiet · Evidence leans down · 96% evidence38.8out of 100GrowthCapitalValuationRelative
  36. 36Bafna Pharmaceuticals LtdBAFNAPH · breaking out · Evidence leans down · 74% evidence35.8out of 100GrowthCapitalValuationRelative
  37. 37Cipla LtdCIPLA · turning · Evidence leans down · 100% evidence35.4out of 100GrowthCapitalValuationRelative
  38. 38Torrent Pharmaceuticals LtdTORNTPHARM · losing its lead · Most evidence points down · 100% evidence34.4out of 100GrowthCapitalValuationRelative
  39. 39Biocon LtdBIOCON · quiet · Most evidence points down · 96% evidence33.6out of 100GrowthCapitalValuationRelative
  40. 40Suven Life Sciences LtdSUVEN · quiet · Most evidence points down · 64% evidence33.1out of 100GrowthCapitalValuationRelative
  41. 41Influx Healthtech LtdINFLUX · quiet · Too little evidence to rank firmly · 42% evidence49.7out of 100GrowthCapitalValuationRelative
  42. 42Syncom Healthcare LtdSYNCOM · Too little evidence to rank firmly · 17% evidence42.3out of 100GrowthCapitalValuationRelative
  43. 43Indoco Remedies LtdINDOCO · losing its lead · Too little evidence to rank firmly · 49% evidence38.4out of 100GrowthCapitalValuationRelative
  44. 44Sai Parenterals LtdSAIPARENT · turning · Too little evidence to rank firmly · 31% evidence36.7out of 100GrowthCapitalValuationRelative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Pharma - Formulators, all 44 compared on one page.

Which companies are close to FDC in size?

FDC is the 28th largest of 44 Pharma - Formulators companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Strides Pharma Science, Suven Life Sciences and Bliss GVS Pharma. Just below it: RPG Life Sciences, Gufic BioSciences and Kwality Pharmaceuticals.

Pharma - Formulators companies close in size

  1. Strides Pharma Science Ltd ₹9,851 crore
  2. Suven Life Sciences Ltd ₹7,314 crore
  3. Bliss GVS Pharma Ltd ₹6,888 crore
  4. FDC Ltd ₹6,138 crore
  5. RPG Life Sciences Ltd ₹4,260 crore
  6. Gufic BioSciences Ltd ₹4,147 crore
  7. Kwality Pharmaceuticals Ltd ₹3,606 crore

All 44 Pharma - Formulators companies, largest first

Companies close in size in other industries

  1. Shrem InvIT ₹6,176 crore · Infrastructure Investment Trusts
  2. Waterways Leisure Tourism Limited ₹6,166 crore
  3. FDC Ltd ₹6,138 crore
  4. Le Travenues Technology Ltd ₹6,138 crore · E-Commerce - Platform - Travel
  5. Equitas Small Finance Bank Ltd ₹6,131 crore · Banks - Small Finance

What else do people ask about FDC?

What is FDC's share price today?

FDC Ltd's share price is ₹390.95, −8.2% over the past year. The whole company is worth ₹6,365 Cr on the market.

In the last 52 weeks it traded between ₹321 to ₹434; today it is 62% of the way up from the low, 3.6% above its 200-day average (as of 4 November 2026).

What were FDC's latest quarterly results?

FDC Ltd reported revenue of ₹572 Cr and net profit of ₹49.0 Cr for the Sep 2026 quarter. Revenue rose 20.9% and profit rose 75.0% compared with a year earlier. Earnings per share were ₹3.01.

The operating margin was 11.0%, 4.0 percentage points higher than a year earlier (as of 4 November 2026).

What is FDC's market cap?

FDC Ltd's market capitalisation is ₹6,365 Cr at a share price of ₹390.95. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026).

How is FDC performing?

FDC Ltd's share price has been falling for 10 weeks. In its latest quarter, revenue rose 20.9% and profit rose 75.0% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 1 week running (as of 4 November 2026).

Will FDC's share price go up?

This page does not forecast FDC Ltd's share price. What it shows instead: the share price is ₹390.95, and it has been falling for 10 weeks. Its P/E of 19.4× is higher than 33% of its own last 11 years (as of 4 November 2026).

Who owns FDC?

Promoters own 69.7% of FDC Ltd, foreign institutions 1.6%, domestic institutions 6.6% and the public 22.2% (latest quarter). The biggest change over the last two years: Foreign institutions cut their stake by 1.1 percentage points over 8 quarters (as of 4 November 2026).

Does FDC have too much debt?

No, FDC Ltd has little debt: its debt is 0.01× its equity, and its operating profit is 69 times its interest bill. FY26 borrowings were ₹15.0 Cr against equity of ₹2,485 Cr. So the returns on this page come from the business, not borrowed money (as of 4 November 2026).

Where is FDC in its business cycle?

FDC Ltd's FY26 operating margin was 16.0%, against a 13-year range of 14.0% to 25.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 11.0%.

Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026).

What could break the FDC story?

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business.

On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026).

Is FDC a stock worth studying right now?

What the numbers show: FDC Ltd's earnings have grown faster than its share price. Earnings per share grew +5.5% in a year while the price moved −8.2%. The main open question: the next one or two quarters of results.

Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026).

Where do these numbers come from?

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.

More lists

Every Sector Alpha list, grouped

X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.